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Abstract
This thesis presents a novel toolkit for image analysis that seeks to improve our
understanding of the structures of the islets of Langerhans within the human Pancreas.
Our aim is to improve understanding of structural changes associated with age and
diabetes.
The islets of Langerhans are structures within the pancreas which are the
metabolic control centres for blood sugar (glycaemic) homeostasis, amongst other
things. These islets contain several endocrine cell types including insulin producing
beta cells and in diabetes this composition changes. One of the major problems
with our understanding of what happens in human diabetes is the lack of available
samples for study. In the University of Exeter medical school, we are able to access
approximately 160 diabetic pancreases, making this the world’s largest collection of
such material.
Due to the progress of diseases such as diabetes being associated with changes
in cellular composition of the islets, we examine the structure of islets both as a
totality and at a cellular level. We have developed algorithms to automate the
mapping of islets from microscopy images to spatially informative false colour map
at a cellular resolution. We begin this analysis with a systematic analysis of the
relevant cell numbers in the pancreas in ex vivo human subjects, with and without
type 1 or type 2 diabetes.
We subsequently investigate this structure by constructing metrics that charac-
terise the geometry of the islets (such as the isoparametric ratio) and how diabetes
may change these. We analyse the topological properties of the islet structure using
recently developed techniques in computational homology and in particular persistent
homology upon individual islets. Specifically, this involves finding generating sets for
the first and second Betti numbers for particular mapped microscopy images and
investigating Betti number stability under perturbations of parameters used for the
automated image analysis.
Finally, we explore cellular network structures within the islets, and how
diabetes may change the pattern of intracellular connections within the islets. We
do this via network metrics which characterise some aspects of the structure of the
networks such as connectedness. We do this considering the graph as an overall islet
network and the subnetworks between different cell types.
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1. Background and Motivation
1.1 Current Understanding of Human Islet Struc-
ture
1.1.1 Pancreas Anatomy
Nested in the duodenum, and anterior to the aorta, the macroanatomy of the pancreas
is relatively well known [3]. Somewhat phallic looking, the pancreas can be divided
into three main areas: The head- in which the majority of the mass lies, body and
tail, which is illustrated in Figure 1.1. The pancreas is relatively unique because it
consists of endocrine and exocrine tissues. The exocrine tissues come in the form
of acini (singular acinus), which are berry like structures and makes up more that
82% of the pancreas by volume. The acinar cells secrete protein digestive enzymes
into the duct system. Commencing from intralobular ducts, this secretion flows to
the interlobular ducts, and finally into the duodenum, through the main pancreas
duct (duct of Wirsung). The ducts are made of thick collagen which prevent the
pancreas from auto-digesting. Damage to the ducts can cause a leak, which triggers
pancreatitis [4].
The endocrine tissue is dispersed throughout the pancreas, in structures called
islets of Langerhans. This dispersion is not uniform; there is increased density of
islets in the pancreas tail [5]. There also exist a small number of beta cells outside of
any islet structure (in groups of 1-3) cells. It is not definitively known why these
cells exist; some authors have proposed that they might be islets in an early stage of
formation.
In the pancreas, much like any other organ, the vasculature oxygenates the
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Figure 1.1: A diagram of the pancreas and a contained islet [1]. The blood vessels oxygenate
the organ. Hormones, including insulin, glucagon and somatostatin are released into the
blood by the islets, located throughout the pancreas which are represented by the dots.
However, the islets are not distributed evenly; there is a similar density of islets in the
pancreas head and body regions, but a greater than a two-fold increase in islet density in
the tail.
tissues present, and supplies energy/nutrients. Blood vessels infuse islets, with a
density five times that of the exocrine tissues [6]. The vasculature plays a key role in
percolating hormones from islet cells, making them an important component in the
islet anatomy.
The nerves present in the pancreas contain a mixture of sympathetic and
parasympathetic types, including sensory nerves. Insulin secretion is stimulated by
the parasympathetic system and inhibited by the sympathetic system. This enables
the islet cells to respond to environmental stimuli such as those triggered by eating
and digestion. The exact synaptic connections within the islet, however, are not
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known to date [7].
1.1.2 Islet Anatomy
The islets are ovular structures, containing a mix of at least five different types of
endocrine cells [2]. α cells secrete glucagon (GCG), which is a hormone that raises
the blood glucose levels. α-cells comprise between 15% and 20% of the number
of islet cells. β cells secrete insulin which lowers blood glucose level. Beta cells
comprise between 50% and 80% of the islet mass. Beta cells also secrete islet amyloid
polypeptide (IAPP), also known as amylin, which works to prevent spikes in glycemic
levels by slowing gastric emptying. δ cells secrete a hormone called somatostatin
(SST), which inhibits glucagon and insulin release. δ cells comprise between 5− 10%
of the volume of islets. γ cells secrete pancreatic polypeptide (PP) which regulates
pancreatic secretions (exocrine and endocrine). ε cells secrete a hormone called
ghrelin and was the most recent cell type to be found (2002) [8]. Functionally, ghrelin
regulates appetite [2].
The islets are surounded by a protective extracellular matrix (ECM) comprised
of two components: The basement membrane (BM) and the interstitial membrane
(IM) [9]. Primarily constituted of collagen and laminins, the BM limits the movement
of cells and soluble molecules. The IM allows the tissues flexibility and elasticity,
and underlies the BM. In T1D, the basement membrane has been shown to undergo
severe degradation [10].
Whilst size and distribution of islets are highly variable, there are two major
types of islets recognised- diffuse and compact islets [11]. Diffuse islets are located
predominantly in the head of the pancreas, and contain significantly more γ cells. In
human islets, endocrine cells are distributed throughout the islet, seemingly without
structure.
1.1.3 Islet Cell Interactions
Within islets, different cell interactions influence the quantity of endocrine hormone
secretion. Most interactions take place via chemical and electrochemical signalling.
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These signals either travel via the islet space (interstitum) or via the local islet
microcirculatory network. All signalling mechanisms that are mediated via the
vasculature can only travel downstream. Here, we are merely outlining some of the
better known mechanisms at a high level. This is a highly active area of research,
and is fundamental to understanding and eventually quantifying how islets work -
both healthy and diabetic ones [12]. The mechanisms are represented in Figure 1.2.
A key interaction within the context of diabetes research are beta-beta cell
interactions. These take place via cadherins, gap junction proteins, eph receptors
- membrane bound proteins, ephrin ligands and secreted insulin. N-, R- and E-
cadherins and a neural cell adhesion molecule are produced in the islets. The N-
and E- variants of cadherin (calcium-dependent adhesion molecules) localize to the
cell-cell contacts, whilst R-cadherin is present in the cytoplasm. These molecules play
a role in glucose stimulated insulin secretion, and help to synchronise the secretion
from adjacent beta cells. Gap junction proteins connect beta cells, and allow ionic
exchanges between neighbouring beta cells which allows for synchronisation of their
ionic cytoplasmic concentration and electrical activity. This provides beta cells
further mechanisms by which to synchronise their insulin secretions [13]. These
mechanisms work over all timescales; Betram et al. provide a mathematical model of
how both fast and slow scale electrical activities combine to create a wide range of
timescales over which insulin secretion happens [14]. Ephs and ephrins work together
to promote insulin secretion in response to low glycaemic levels. In this context blood
glucose concentration is the primary metabolic signalling agent. Secreted insulin
acts to inhibit further insulin secretion, via a negative feedback mechanism [15].
Beta-beta cell interaction are not the only source, or even the primary driver
of insulin secretion. Insulin secretion happens constitutively, though it it is increased
primarily as a result of high blood sugar levels. High blood sugar levels trigger
the closure of potassium sensitive channels in the beta cells causing membrane
depolarisation [16]. This membrane depolarisation, in turn stimulates electrical
activity, which in turn triggers calcium ion influx and insulin release [?].
Alpha cells produce glucagon at an increased rate when blood glucose levels
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are low. Alpha - alpha cell connections cooperate positively as glucagon promotes
its own secretion via an unknown positive feedback mechanism. Beta cells secrete
ionic zinc as part of the mechanism for producing insulin. This ionic zinc acts as an
electrochemical inhibitor for glucagon secretion from alpha cells. Glucagon acts as a
signalling agent to promote beta cells insulin secretion and delta cell somatostatin
secretion via membrane receptors [17].
Delta cells interact with both beta and alpha cells to inhibit their secretions.
The production of somatostatin in delta cells is promoted by the presence of glucagon
















Figure 1.2: Network diagram displaying different kinds of cooperative or inhibitive relations
between cells in the islets. Beta cells synchronise with each other. Insulin also inhibits
the production of glucagon in the alpha cells. Alpha cells also produce glucagon which
simulates both insulin and somatostatin production. Delta cells produce somatostatin
which inhibits the other two hormone productions.
1.2 What is Diabetes Mellitus?
1.2.1 Medical Definition of Diabetes Mellitus
Diabetes Mellitus is characterised by poor control of blood glucose (glycaemic) levels.
The World Health Organisation (WHO) defines diabetes as a blood glucose level of
> 11.1mmol/l 2 hours post-prandially (following a meal), whereas, normal blood
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sugar is < 7.8mmol/l [18]. Diabetes can be characterised as a disruption within the






















Figure 1.3: Simplified representation of glucose homeostasis system. Glucagon and insulin
are the two primary hormones which modify glycaemic levels, thereby maintaining blood
glucose homoeostasis in healthy individuals. Insulin works to lower blood sugar levels
and glucagon raises blood sugar levels. Diabetes occurs when the subsystem encompassed
within the blue square malfunctions.
Whilst many types of diabetes exist and will be explained in due course, there
are two main types; type 1 diabetes (T1D) and type 2 diabetes (T2D). There is no
concise definition for either, but typically, T1D is an autoimmune disease, occurs
in young patients - the mean T1D onset age in US is 14 - and requires exogenous
insulin to manage [19, 20]. T2D is typically a disease of older patients - the mean
onset age in the US is 45. It is thought to be mediated by reduced insulin sensitivity
in peripheral tissues and a decline in insulin secretion and can often be managed by
lifestyle changes as well as orally activated agents and/or injected insulin where this
proves to be insufficient [21, 22].
There is a third classification, though not universally accepted, amongst this
spectrum, called type 1.5 diabetes or latent autoimmune diabetes in adults (LADA).
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Patients typically present with characteristics associated with both T1D, such as
autoimmune beta cell destruction, and T2D, such as older age of onset [23, 24].
Due to imprecision about the classification and heterogeneity of how diabetes
presents, a recent study identified 5 different clusters of diabetes patients. This
data driven study, using K-means classifications and hierarchical clustering identified
the following, based on factors including genetic similarities, treatment and disease
progression. Cluster 1, or severe autoimmune diabetes (SAID) was characterised by
early-onset disease, relatively low BMI, poor metabolic control, insulin deficiency
and the presence of glutamic acid decarboxylase antibodies (GADA). Antibodies
to GADA are an autoimmune marker that indicates substantial autoimmune islet
inflammation and is discussed in section 1.3. Cluster 2, or severe insulin-deficient
diabetes (SIDD), was GADA negative but otherwise similar to cluster 1: low age
at onset, relatively low BMI, low insulin secretion, and poor metabolic control.
Cluster 3, or severe insulin-resistant diabetes (SIRD) was characterised by insulin
resistance and high BMI. Cluster 4, or mild obesity-related diabetes (MOD) was
also characterised by obesity but not by insulin resistance. Finally, cluster 5, or mild
age-related diabetes (MARD) were older than patients in other clusters, but showed,
similar to cluster 4, only modest metabolic derangements [25]. Though more work is
required on this classification methodology, a similar endotype classification has been
attempted with respect to type 1 diabetes [26]. As we increase our understanding of
the disease and are able to classify it better, it is hoped that we may be able to treat
and possibly even cure or prevent both main types diabetes in humans.
As a brief aside, it is worth mentioning that there are other types of diabetes,
though these will fall outside the scope of this project [27, 28, 29].
1.2.2 A Brief History of Diabetes
The term diabetes mellitus comes from Greek and Latin. ‘Diabetes’ comes from
the Greek work for syphon and ‘mellitus’ comes from the Latin for honey-sweet.
Together, these describe one of the main symptoms of the disease, which is excessive
urination of glucose containing urine.
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Diabetes has been known to exist since ancient times [30]; a symptomatic
description appeared on the Ebers papyrus in 1550 BC. Subsequently, a distinction
between what is now called type 1 and type 2 diabetes was made in 5th and 6th
century AD in India by physicians such as Sushrut. Whilst the sweetness of urine
was rediscovered in Europe by the English court physician, Thomas Willis in the 17th
century, it took until the following century for another English physician, Matthew
Dobson, to show that the diabetic sweetness of urine was a result of sugar [31].
Perhaps the most famous name associated with diabetes physiology is Paul
Langerhans. In his doctoral thesis, 1869, he was the first person to describe clusters
of cells, later known as islets of Langerhans. The next great leap in our understanding
of diabetes came in 1899. Oskar Minkowski and Josef von Mering, removed the
pancreas of a dog inducing diabetic symptoms, which for the first time showed that
the pancreas was a vital component with respect to diabetes. Insulin, from the Latin
for ‘island’ was discovered in 1921. Following testing on dogs, the first diabetic
human was treated with injected insulin in 1922. [32].
Determining the amino acid structure of insulin and its three dimensional
structure using X-ray crystallography was achieved during the 50’s and 60’s by two
Nobel prize winners, Frederick Sanger and Dorothy Hodgkin, respectively. In the
80’s, major advances occurred in the production of insulin. Using additives such
as zinc, it has become possible for the absorption of insulin to be controlled from
the sub-cutaneous insulin injection, mitigating some of the side effects caused by
injected insulin [33].
More recently, advances in ‘big data’ and mathematical techniques, such as
machine learning are allowing us to develop better treatments for diabetes, such
as automated insulin pumps - using glycaemic sensors to calculate the quantity of
insulin to be injected, and be able to better predict risk of developing diabetes [34].
1.2.3 Epidemiology of Diabetes
The risk factors for developing diabetes are multivariate, and include both envi-
ronmental and genetic causes. In general the global prevalence of diabetes stands
8
at 9.3% as of 2019, which is expected to rise to 10.2% in 2030 [35]. There exists,
however, significant regional variability within both types of diabetes, due to the
compounding of different epidemiological geographical risk factors. For T1D, this
ranges from incidences of 0.0001% in China and Venuzuala, to 0.0365% in Finland
[36]; For T2D, this ranges from about 4% amongst the Mapunche Indians in Chile
[37], to 38% among the Pima Indians [38].
Age is a significant epidemiological factor determining type of diabetes that
one is likely to develop. Over 85% of diabetes patients under the age of 20 have T1D.
Diagnosis of T1D peaks around 10-14 years of age [39]. On the other hand, T2D is
more commonly a disease of elderly people, though there is a large increase in cases
of young onset T2D, thought to be as a result of the increase in global incidence of
childhood obesity [40, 41].
Obesity is considered the primary cause of T2D; about 80% of new cases of
T2D present as obese [42]. The risk of developing T2D increases with respect to
BMI; medically obese people are 6-10 times more likely to contract diabetes in their
lifetime according to the NHNANES survey in the US, compared to the general
population [43]. Obesity is considered to be a significant risk factor in T1D [44],
with a particular study in Finland linking a 10% age relative weight increase to a
60% increase in the risk of developing T1D [45].
Independently of obesity, other lifestyle factors are considered a substantial
risk factor for T2D. As a result, urban populations are more likely to develop T2D
[46]. Exercise lowers the probability of developing type 2 diabetes. Patients who
exercise the most have a 25− 60% lower risk of developing type 2 diabetes compared
with the background population, notwithstanding other factors [47]. Furthermore
diet appears to be another lifestyle factor; a diet, containing high levels of sugars
and fats, combined with low fibre increased insulin resistance by 5.7%. In the case
of T1D, there appears to be increased prevalence diabetes for those born in winter
months [48]. There also appears to be some risk factors associated with diet, such as
how long a child is breast fed for [49].
In terms of genetic risks, two specific genetic markers (haplotypes) have been
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identified on the 6th chromosome, specifically the human leukocyte antigen (HLA)
complex. Whilst 90− 95% of young children who have T1D have either or both of
these haplotypes, specifically HLA-risk genotypes DR3/4-DQ8 or DR4/DR4, about
5% of these develop T1D [50]. There are over 80 genetic loci strongly associated
with type 2 diabetes, and whilst each loci appears to have only a minor impact on
T2D heritability, this indicates that there is a strong genetic risk to the inheritance
of T2D [51].
1.2.4 Symptoms of Diabetes
Diabetes causes many symptoms, as a result of the increased blood sugar levels
(hyperglycaemia). Hyperglycaemia causes changes to capillary architecture and per-
meability, causing many complications, including organ failure , which if uncontrolled
can be fatal. A key motivation for studying diabetes is to enable us to prevent these
complications can be extremely life limiting and painful.
A particularly dangerous outcome of diabetes is a condition called diabetic
ketoacidosis (DKA), which is caused by uncontrolled blood sugar levels. It is
characterised by hyperglycaemia and hyperketonaemia (high levels of ketones in
the blood). The high levels of ketones lowering the pH of blood, also known as
metabolic acidosis. In turn, this can lead to include nocturia and polyuria, weight
loss, weakness, blurred vision and respiratory acidosis; a medical emergency in which
oxygen cannot be effectively transported by the haemoglobin. More symptoms
include abdominal pain, leg cramps, nausea and vomiting, confusion and drowsiness
and in 10% of cases, a coma. DKA is most associated with type 1 diabetes, though
not exclusively. [52]
Diabetic eye disease, one form of which is diabetic retinopathy may be expe-
rienced by most people with diabetes over a 25 year period [53]. Hyperglycaemica
triggers the production of more capillaries in the retina. However, these are weak
and prone to bursting, causing a condition called diabetic macular edema which, if
untreated, can cause total blindness.
Diabetic nephropathy is characterised by proteinuria (high concentrations
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of protein in the urine), which is a sign of impaired renal (kidney) function [54].
Nephropathy includes a large number of disorders, with symptoms including muscular
wasting and deformity.
Diabetic neuropathy is diabetic induced damage to the nervous system, espe-
cially in the limbs. It is caused by diabetic induced microvascular damage. Symptoms
can include loss of senses and extreme pain [55].
Other diabetic complications include increased risk of macrovascular disease,
such as strokes by 3-5 times [56]. The risk of diabetic patients having to have legs,
toes and feet amputated is increased 10-30 times. Erectile dysfunction occurs 10-15
year earlier in men with diabetes as without [57]. Further, diabetes can also cause a
wide spectrum of gastrointestinal problems. Diabetes has been linked to skin and
connectivity disorders, as well as psychological and psychiatric disorders.
1.2.5 Cost of Diabetes
According to a 2019 Diabetes UK report, 4.7 million people in the UK had diabetes,
with a new diagnosis every two minutes. Of these, 90% had T2D, 8% had T1D and
the remainder have rarer types of diabetes [58]. The number of people in the UK,
diagnosed with diabetes has doubled in the last 20 years and by 2030, it is estimated
that more than 5.5 million people will have diabetes in the UK.
The NHS spends about £10 billion a year on diabetes, which accounts for 10%
of its entire budget. Of this, £8 billion is spent on treating complications of diabetes,
whilst an estimated 3 in 5 cases of T2D can be prevented [59]. People with diabetes
are twice as likely to be admitted to hospital and one in six people in hospital have
diabetes. Diabetes leads to more than 8500 leg, toe or foot amputations every year
and 1700 people become visually impaired as result of diabetes. This leads to a loss
of independence, which is not accounted for in the £10 billion. On top of this, fewer
than 1 in 5 T1D patients are meeting their recommended treatment targets that will
lower their risk of complications, whilst the corresponding figure for T2D is fewer
than 2 in 5.
In the US, the indirect and direct cost of treating diabetes was estimated
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to be $245 billion per annum [60]. Aggregated together, the global annual cost of
diabetes is $825 billion and set to rise [61]. This economic burden, along with the
suffering caused by diabetes as illustrated throughout this section, provides sufficient
motivation to study and understand diabetes better, with the eventual aim to cure
the disease.
1.3 Current Understanding of Diabetes Aetiology
Despite large amounts of research, the underlying causes of diabetes remain poorly
understood. This is problematic as it is limiting our ability to treat the diseases, in
both type 1 and type 2 cases. Much of our understanding comes from animal models,
including the non-obese diabetic (NOD) mouse and the biobreeding (BB) rat model.
1.3.1 Current Understanding of Type 1 Aetiology
The main underlying cause of T1D is thought to be an autoimmune mediated
destruction of beta cells, known as insulitis, within the islets of Langerhans. In
younger onset cases, this destruction causes inflammation and lesions in the pancreas.
T1D causes approx 90% of beta cell destruction in lab animals and a 50% to 80%
reduction in plasma insulin concentrations. Creating a toolkit to quantify this
destruction in humans as opposed to animals is a key aim of this project.
The clinical presentation is the final stage of the onset of T1D. In the months
before this, it has been hypothesised that circulating immune antibodies build up
to a threshold, indicating that white blood cells have been causing autoimmune
destruction, at which point the disease develops. However, not all individuals who
have these antibody markers progress to developing T1D. For a more complete
timeline of autoimmune mediated destruction, we have to rely on animal models. For
insulitis, it seems that an acute bacterial or viral infection of the pancreas triggers
a strong autoimmune response, in which the leucocytes misidentify beta cells as
non-self agents [62]. In non insulitis cases of T1D, chronic infections of the islets
trigger a slower destruction of the beta cells, leading to diabetes [63].
Beta cells are assumed to secrete chemokines, attracting white blood cells, as
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outlined by Wilcox et al. [64]. However, various authors have proposed different
white blood cells taking an active role in T1D aetiology. Within the literature,
there is a lack of consensus over these autoimmune mechanisms underlying T1D
[65, 66, 67, 68].
Another key factor during the period T1D onset, of which we are uncertain
about is the so-called ‘honeymoon’ period. This term refers to the time after the
destruction of beta cells in which the diabetes goes into temporary remission. It
is uncertain how this happens, though one hypothesis is that there is a positive
feedback loop regarding the destruction of beta cells increasing the strain on the
remaining ones.
1.3.2 Current Understanding of Type 2 Aetiology
Whilst there is no consensus on how T2D develops, the literature suggests there
are two main components involved in type 2 diabetes pathophysiology - beta cell
dysfunction and insulin resistance, though it is still debated as to which one is the
primary driver of T2D [69].
1.4 Morphometry
Morphometry comes from Greek and roughly translates to measurement of shape/form.
In this thesis, we use morphometry to better describe how the islets change as a
result of diabetes. We are particularly interested in the islets as a structure as there
is a large body of evidence to suggest that the environment of the beta cells affects
function [70, 71].
1.4.1 Use of Morphometry in Mathematical Biology Re-
search
To date the brain is the main theatre in which Morphometry has been used. There
are three main types of morphometry used; Voxel-based, deformation-based and
tensor-based morphometry. The data used in these morphometry methods are
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magnetic resonance imagery (MRI) scans as MRI scans can quantify grey and white
brain matter with a highly reliability. [72]
Whilst it is largely suitable to use 3D morphometry to investigate brain
structures, we do not have access to 3D data in this project, and as such we will be
using 2D morphometry. There is currently a growing body of work in which feature
detection and image analysis are being used in biological research [73, 74].
Published in June 2020, Samber et al. used synchrotron X-ray fluorescence to
conduct an analysis of an islet. In this study, they investigated the presence of K, Ca,
Fe and Zn ions present in the islet, with a view to analyse the shape and distribution
of cells within islet to a spatial resolution of 500nm [75]. Ca and K ions play a key
role in insulin secretion moderation, Zn ions play a role in insulin formation and
Fe ions are implicated in beta cell dysfunction and death. By understanding the
prevalence and spatial distribution of these ions, both under low and high insulin
conditions, Samber et al. hoped to add new insights into islet functions.
1.4.2 Gestalt Principles
A particular form of 2D morphometry that has been recently used in diabetes
research are Gestalt principles. Gestalt is German for ‘shape’ and refers to how the
mind groups similar images and fills in the gaps in order to perceive an amenable
version of reality [76]. In this research, Dybala et al. use the idea of a stereotypic
islet architecture to ‘fill in the blanks’ and complete the missing data from an islet
microscopy scan to get a full picture of what a human and mouse islets looks like.
This could prove useful as there is no stereotypic human islet, so maximising the use
out of existing data is highly important [77].
1.4.3 Persistent Homology in Mathematical Biology Re-
search
Persistent homology is the method to study structural variation in data over a
spatial parameter. Whilst the study and measure of abstract structure has not been
conducted yet in islet research, in the wider field of mathematical biology research,
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it is a new but promising field. Thus far, it has been used in fields such as protein
structure [78] and branching topologies of plants [79] to advance our understanding of
these concepts. In this piece of work, we will be using it to further our understanding
of islets structure and diabetes.
1.4.4 Networks in Diabetes research
Networks theory applied to cellular composition in islets is relatively new but it is
promising because the function of the islets depends on a network of the component
parts. Stožer et al. modelled beta cell islet subnetworks, primarily considering
calcium ions in mouse islets [80]. They investigate how mouse T2D affects the
subnetwork connectivity and provides evidence that T2D lowers the connectivity of
the islets.
Published in 2020 by Xavier et al., beta cell subnetworks have been identified
as drivers for insulin secretion, and ‘hub’ or highly connected beta cells coordinate
the action of other beta cells in the network. [81]. The research has been done using
calcium imaging of mouse islets, from which it was deduced that these ‘hub’ cells
had increased levels of the enzyme, glucokinase present. Understanding how the beta
cells are connected within the islets is the next step to increasing our knowledge of
beta cell functionality.
1.5 Overview of Thesis
Having outlined the problems that we wish to explore, above, this body of work will
seek to primarily create a toolkit to add to the current knowledge of human islets of
Langerhans. Broadly speaking, we will be comparing islet samples of young onset
T1D with their respective controls, older onset T1D with their respective controls,
and finally T2D and their respective controls. We then seek to draw some initial
conclusion about changes, if any, that diabetes has on the islets of Langerhans, based
on the small number of samples that we have. Our aim is to seek to demonstrate the
feasibility of this methodology, which would allow us to draw stronger conclusions,
should we gain access to a larger quantity of human data.
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In chapter 2, we assemble an algorithm to convert micrographs to useable
spatial data. The chapter considers a simple aggregation of the cell numbers between
diabetic groups and their controls, and statistically compares them. This algorithm
is novel in that, to our knowledge, is the first uses of feature detection and cell
segmentation in an automated manner for islets of Langerhans.
Subsequently, in chapter 3, we use the spatial segmentation generated in
chapter 2 to construct and utilise various spatial data to investigate various changes
in the islets as a result of diabetes. The novelty here is that this is the first time
that aspects of the geometry of the islets of Langerhans have been automatically
analysed and quantified in order to assess the impact of diabetes.
Geometry can be considered as a spatial manifestation of topology. In chapter 4,
we utilise persistent homology to analyse the underlying structures of the islets, and
how diabetes may change this. This is the first time that topological analysis has
been used in the field of diabetes research, and should be considered more as a proof
of concept.
By considering the geometry and topology, in chapter 3 and chapter 4, we
are analysing the macrostructure of the islets. We are also interested in further
understanding how the microstructure of the islets changes as a result of diabetes.
In chapter 5, we use the processed data from chapter 2 to generate networks based
on the Voronoi partition between the identified cells in the islets. We then analyse
how diabetes affects this underlying structure.
Chapter 6 finishes with a critical discussion of the results in the thesis. In this
chapter, we collate the results from the thesis and use this to pose future hypothesis
that can be assessed with additional data. We then suggest some direction for future
research question that result from the work in this thesis.
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2. Extracting Islet Structures from
Micrographs
The aim of this chapter is to enable us to develop a more accurate understanding
of the islets of Langerhans’ cellular composition, in different subjects before and
after the onset of diabetes. We compare the test subjects’ cell counts with the
control groups and the results have been validated by comparing our results to those
obtained manually by the University of Exeter Medical School (UoEMS). We will
then use this processed data in subsequent chapters, to further investigate how the
islet structure, from geometric, topological and network perspectives, is altered by
diabetes.
The Chapter is structured as follows: in section 2, we outline the algorithm
used to analyse the micrographs as obtained from the UoEMS, followed by statistical
analysis of these results. In section 3, we outline the in silico model that we will
use in conjunction with the work in section 2 to improve our understanding of the
aetiology of T1D and in section 4 we discuss and summarise the results of this
chapter.
In future work, we would aim to process the images of T1D controls to serve
as an input for a computational model for insulitis (further details are provided in
Appendix C). The model will then simulate beta cell destruction using islet geometry
extracted from the control subjects’ images and output an in silico post-insulitis
image. This image will be statistically compared to the processed T1D patient
images, in order to draw conclusions about the underlying mechanisms of T1D beta
cell destruction as stated in the thesis aims.
Despite the prevalence and serious nature of diabetes, very little is known about
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the aetiology of this disease, which hinders effective treatment. Current methods of
treatments include insulin injections, mostly for T1D [82], whilst for T2D, lifestyle
changes are the preferred initial treatment [83]. Treating diabetes patients with
exogenous (artificial, injected) insulin has severe side effects, including hypoglycaemia
and hypokalemia (low blood potassium) [84]. Therefore a lot of research effort is
concentrated on finding alternative ways for treating T1D patients that would negate
the need for exogenous insulin, including islet transplants [85] and autoimmune
therapy [86]. However, these approaches have been unsuccessful, despite Serup et
al. predicting in the BMJ in 2001, “islet cell transplantation is likely to become
the treatment of choice for most insulin dependent diabetics within the next five
to ten years” [87]. Whilst islet transplantation works well, the treatment does not
due to the limited supply of islets to transplant. The lack of success in all of these
experimental treatments outlined in this paragraph can be partially attributed to
the poor understanding of the architecture of the human pancreas and the islets [88].
A major reason for this lack of understanding is a shortage of human data as
the pancreas rapidly self digests after death as a result of the enzymatic action of
the organ’s acinar tissues [3]. Furthermore, it is also difficult to access the pancreas
due to its recessed location, anterior to the duodenum [3]. For this reason, much of
the previous research has focused on non human islets as they are easier to obtain.
Hence, our understanding of insulitis in animal models, such at the BioBreeding rat,
is much better than in humans. [89]. Additionally, human islets behave differently to
animal models [90], explaining why making further progress towards understanding
human type 1 diabetes is challenging.
We are particularly interested in quantifying the number of beta cells in an
islet in order to better understand the progression of diabetes. Brissova et al. [91]
used murine islets to quantify alpha, delta and beta cells. Their method summed the
intensity (on an 8-bit scale) after immunolabelling each of the hormones, per pixel,
within the islet. From this, the percentage of an islet that each of these hormones
occupied was recorded and compared to each other. However, the main drawback of
this approach is that it does not identify individual cells, which limits the information
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available, such as quantifying the number of cells in an islet. We are interested in
this detail, particularly the number of beta cells, to precisely quantify the effects of
diabetes and age on the islets via measuring the amount of hormones and pancreatic
cell numbers.
An algorithm to analyse 3D mouse and monkey islet images has been developed
in 2017 by Nhu et al. [92] . They apply this in a case study to analyse the structure
and composition of 3D animal islet images. Their conclusions relate to the structure
of animal islets, such as 3D clustering of alpha cells in murine islets. The specifics
of their algorithm differs from ours, for example, they used a watershed algorithm
[93] to identify the nuclei, which by their own acknowledgement, resulted in dense
clustering and overlaps of nuclei in the islets, hence making cell counting problematic.
By contrast, we used a local filter combined with an erosion algorithm (see image
analysis section section 2.2) to help resolve this inaccuracy in nucleus identification.
Despite the difficulty in acquiring ex vivo human islets and the subsequent
sparse literature, it is known that human islet architecture changes as a result
of diabetes [94]. A deeper knowledge of the morphology of the human islets of
Langerhans is required to better understand the significance and role of insulitis
with respect to diabetes. This includes a comprehensive knowledge of the ratios of
different cell types throughout the islets, both before and after the onset of diabetes.
Bosco et al. [95] have performed some analysis of human islet morphology. Their
method involved comparing the ratios of the different hormones to each other, in
the same manner as Brissova et al. They then further assessed the architecture by
manually comparing the cells exclusively around its periphery and vasculature. By
focusing on cells only in this region, this study was limited in the conclusions that
could be drawn as these parts of the islet are not necessarily representative of the
totality of the islets. Their work also demonstrated that human islets have a unique
architecture - important for islet functionality, when compared to animals. However,
to date, no studies have been undertaken to understand directly how diabetes affects
human islet morphology, and existing animal models of T1D aetiology cannot be
simply translated for humans [96].
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Historically, image processing techniques on islets have often been performed
by hand on individual images. This has included human islet images such as that
done by Kilimnik et al. [97]. However, only limited conclusions could be drawn from
islet architecture, due to the methodology limitations as identified above. By way of
example, an important factor with respect to the onset of diabetes (especially T1D)
is beta cell loss; this quantification has not been done in a systematic manner to
date. Additionally, manual implementation of algorithms is subject to human biases.
Therefore processes that are fully automated are desirable in order to extract reliable
quantitative information from the available islet microscopy images.
2.1 Description of Data Set
Recently the group of Professor Noel Morgan in the University of Exeter Medical
School took microscopy images on a large number (250) of ex vivo human islet sets
(example of image given in Figure 2.1). Each islet image set consists of 5 images: A
DAPI stained image which we use to extract information about where the nuclei are
in the islets. DAPI is a chemical which binds to DNA and fluoresces when exposed to
certain wavelength of light; the three hormone stained images (insulin, glucagon and
somatostatin) which we use to extract information about the boundaries of the islets
and the types of cells present; and the final image is an overlay of the previous 4
images. This gives us a total of 1250 images for analysis. The image sets themselves
are divided into three: Older onset T1D and their respective controls; young onset
T1D and their respective controls; finally, T2D and their respective controls. These
cases are age and sex matched with their respective control groups, based on the
material available from the Exeter Archival Diabetes Biobank (EADB). Young onset
usually means below 12 years of age and older onset is above this age.
The microscopy images come in the form of tagged image file format (.TIF)
and the image resolution is 1296 by 966 pixels. The images were taken at a 20×
magnification on a LEICA DM4000 B-LED fluorescence microscope using LAS X
image software, with a conversion scale between pixels and units of 25µm per 92
pixels. islets were selected at random, by searching the tissue under a particular
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(a) DAPI stain of example islet image (b) Glucagon stain of example islet im-
age
(c) Insulin stain of example islet image (d) Somatostatin stain of example islet
image
(e) Coloured overlay of all the above hormones
Figure 2.1: An islet immunofluorescence microscopy image set. Figure 2.1a represents DAPI
(dark blue in Figure 2.1e), which fluoresces to indicate the presence of nuclei. Figure 2.1b
shows glucagon (red in Figure 2.1e), which is a hormone that raises the blood glucose
levels. Glucagon is secreted by alpha cells, which make up between 15% and 20% of the
number of islet cells. Figure 2.1c is insulin (light blue in Figure 2.1e), which is a hormone
that works to lower blood sugar levels. Insulin is secreted by beta cells, which comprises
between 50% and 80% of the islet mass. Finally, Figure 2.1d is somatostatin (green in
Figure 2.1e), which is a hormone that inhibits glucagon and insulin release. Somatostatin
is secreted by delta cells which comprises between 5% and 10% of the islet mass. There are
also two other cell types that the microscopy image does not display; gamma cells which
secrete a hormone called pancreatic polypeptide (PP) that regulates pancreatic secretions
and epsilon cells, which secrete a hormone called ghrelin that regulates appetite [2].
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wavelength at which glucagon fluoresces (555 µm) to identify the islets. Numbers of
patients and total islets per group are included in Appendix A.
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Figure 2.2: The flowchart outlines the image processing workflow. Briefly, the images are
imported into an array and processed using primarily image filters. Subsequently, we use
these processed images to decide what cells the image data corresponds to. The images
are then further processed so that they can be used as an input for a cellular automata
model of type 1 diabetes Appendix C.
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The programming components of this work were conducted in Python3. Stan-
dard image processing techniques were employed using the scikit image library [98].
All of the linear algebra operations used the NumPy library [99]. Statistics were
done using the scipy stats library [100]. Each of the images were read into a pre-
dimensioned array object to 1296× 966× 3, corresponding to the image dimensions
and the overlay or stack of red, green and blue images, respectively. The objective
of the image processing was to convert the microscopy images to quantifiable data
with respect to the types of cells present, the outline is displayed in Figure 2.2. We
then downsample (reduce the resolution of) the images so that they may be used
as an input for a in silico insulitis model. Outlined below is the methodology via
which this is achieved. The scale on these images is 25µm per 92 pixels - which we
denote as Sc. It is also useful to define here the processed islet outline black and
white (binary) images B which is the member of the set of processed islet outline
binary images B.
2.2.1 Removing Blood Artefacts From the SST Image
The first image processing step was to remove blood artefacts from the somatostatin
(SST) images, which we denote with T . Under the wavelength that the SST was
imaged at, blood fluoresces. Subject specialists can tell the difference between the
blood and somatostatin as somatostatin appears as granular objects, whereas blood
appears as a blurry circular shapes. To differentiate the two, we took the Laplacian
of the somatostatin image. A Laplacian is an operator that measures the magnitude
of the second order derivatives, blurry objects have a low magnitude under the
Laplacian filter, whereas granular objects have a much higher magnitude. Acting on











(a) This SST image comes from a T2D control patient. There is a
large quantity of dull background green within the islet, representing
the blood and some small grain blobs in the foreground, representing
the presence of SST cells.
(b) This is the mask as generated from Figure 2.3a using a Laplacian,
Gaussian blur, and triangle filter as outlined above
Figure 2.3: Demonstration of the process for preprocessing the SST images.
where T is the gray-scale SST image array; This is approximated and implemented




(Ti+1,j + Ti−1,j + Ti,j+1 + Ti,j−1 − 4 · Ti,j) , (2.2)
where, i and j are indexes representing the horizontal or x and vertical or y pixel
positions respectively. We then apply a Gaussian blur, using the scikit image library
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[102], with a parameter of 1 pixel to smooth the data, followed by a triangle filter,
from the scikit image library [103] to create a mask for the SST image. A mask is
a binary array where values take either true or false. Both the triangle filter and
the Gaussian blur are explained in more detail below. By applying the Hadamard
product (also called entry-wise product) between the original image and the mask,
the original image is allowed through where the mask is true (1) and where false (0),
the value of the new image array is also zero. This is displayed below in Figure 2.3.
A Gaussian blur is used to smooth an image to account for noise, obtained
during the microscopy process, although this reduces the detail of the image. The
blur works by convolving each pixel upon its corresponding discrete Gaussian kernel.
The Gaussian kernel in a two dimensional space, i, j, can be expressed as:







where i and j are the pixel location in the ‘x’ and ‘y’ directions. σ is the standard
deviation, which represents a blurring coefficient. For us, in the SST image, this
coefficient was 1, which was arrived at by a parameter search combined with visually
inspecting the image. > 1 resulted in outlines that lost too much detail regarding
the areas of the mask. < 1 resulted in images that were disjointed and did not
sufficiently capture the macroscopic details of the SST mask.
Subsequently, we needed to identify the islets from the background of the image.
The triangle filter is an image processing method to separate a foreground from a
background. The method is appropriate for images that have a histogram which is
unimodal. The histograms of our islet images are highly unimodal histograms, as
shown in Figure 2.4a. This algorithm has been used in bioimage processing since
1977 to split a foreground and a background [104].
Firstly, the SST, Insulin and GCG channels are combined and converted to
grayscale. The intensity of each pixel is recorded and used to generate a histogram.
The horizontal axis is categorised into bins, denoted by xi, i ∈ 0..256, corresponding
to the possible quanta of intensity from 8 bit images (28 = 256). Each xi has
corresponding frequency, Hi. Secondly, we find the both index, i = M , corresponding
26
to the max histogram frequency (2.4) and the index, i = m, corresponding to the




m = max{j | Hj 6= 0} (2.5)
The triangle filter [104] is applied to this image by drawing a straight line (L1)
between the Cartesian points (xM , HM) and (xm, Hm). Following this, the distance,
dj is calculated perpendicularly from L1 to Hj (2.6), j ∈M...m, and the argument
j = T is that at which dj is maximal (2.7).




xT is determined to be the threshold value. This is illustrated below in Figure 2.4b.
2.2.2 Finding Islet Boundary
To find the boundary of an islet, we aggregated the 3 hormone stains, insulin,
glucagon and somatostatin to form a grayscale image, via addition. From that, to
smooth the image, we took the Gaussian blur, with a smoothing parameter (σ value)
of 10. This parameter value balanced the need on one hand to smooth the noisy
data (the higher the parameter the better the smoothing) with the need to preserve
important information about the shape of the islets (the lower the parameter the
less data lost). We then applied a triangle filter on this Gaussian blurred image to
create a binary image in which 1 represents a point in the islet and 0 corresponds
to a point in the background tissue. However, despite smoothing the image, there
were still small regions of pixels outside the islet and small holes in the islets (this
can be seen in Figure 2.5d), which was resolved by removing small objects and
holes with areas under 1000 pixels; a balance between removing visual artefacts and
not removing “legitimate” features, arrived at by using a visual inspection and a
parameter search. This was done by implementing an algorithm from scikit-image
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Figure 2.4: (a) Typical image histogram; (b) A diagram presenting the idea of the triangle
filter.


















(a) A histogram of the example image in Figure 2.1. There are 256 bins, with
each bin corresponding to a level of intensity in the image. Each Column is
the number of pixels with that particular intensity. Note the highly uni-modal









(b) A diagram illustrating how a triangle filter works on a histogram of an
image to generate a threshold. Step 1 is to generate a 256 binned histogram of
the image, the peaks being represented by the thick black line on the diagram.
Step 2 is to locate the bin with the maximum intensity and draw a straight line
from this peak to the highest pixel intensity present (L1). Step 3 is to draw a
perpendicular line from the previous line to the histogram peak line, with the
maximum Euclidean distance (L2). Finally, the point on the histogram line
at which the perpendicular line gives the threshold between foreground and
background.
[105] and a comparison of an image and its processed boundary are provided below,
in Figure 2.5. We denote binary image matrices of the islets as B.
2.2.3 Finding the Nuclei of the Islet Cells
We wished to find points, unique to each cell, in order to segment the cells within
the islets. Nuclei are unique to each cell, so by finding points near the centres of
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(a) This is the overlay of the images that we are using in this
example
.
(b) This is the result of aggregating the
insulin stain, the glucagon stain, and
the post processed somatostatin stain,
as shown in Figure 2.5a. This a false
colour grayscale image
.
(c) This was the result of applying a
Gaussian filter with a smoothing param-
eter of 10 pixels on Figure 2.5b
(d) This was the result of applying a
triangle filter to separate the foreground
from the background in Figure 2.5c
(e) This was the result of removing the
small objects, which we deemed to be
’noise’ from Figure 2.5d
Figure 2.5: The 4 image processing steps taken to deduce the islet boundary from the
three endocrine hormone stained images.
nuclei, we have points around which to segment cells. For this, we used the DAPI
stains, as DAPI binds to DNA, which appear as luminous circular objects on the
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(a) Original DAPI stained image. Note the nuclei overlap in
highly dense regions, causing a ‘glowing’ effect.
(b) DAPI processing step 1, apply a local
filter to Figure 2.6a
(c) Apply the islet mask as generated in
Figure 2.5 upon the image as generated
in Figure 2.6b. This removes nuclei that
are not in the islet.
(d) Removal of small objects and holes
from Figure 2.6c
(e) Erosion algorithm on Figure 2.6d,
to remove noise and disentangle nuclei.
Displayed in the image are blob frag-
ments of nuclei. We are only interested
in where the centres of these blobs and
by extension, nuclei are, with a mod-
elling assumption that these are the cen-
tres of the cells.
Figure 2.6: The image processing steps outlined above are required to identify where the
centres of the nuclei are.
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images. However, these circular objects express a halo [106], which means in high
nuclei density regions, such as the islets, the non nuclei parts of the islet can be
just as bright as the nuclei in the background region. Consequently, using a filter
with a uniform threshold such as a triangle filter would be inappropriate here. We
therefore used an adaptive threshold filter, or local filter to achieve this. This works
by determining the mean pixel intensity of a surrounding 101 by 101 square pixel
object, and using the resulting value as the threshold value for that pixel (shown in
Figure 2.6b). Objects with a smaller pixel area resulted in areas outside the nuclei
being above the threshold, and a larger pixel area resulted in large swathes of the
islets in their entirety being above the threshold value.
This process resulted in a noisy image, so to further rectify this, we removed
small holes and objects under 100 pixels (shown in Figure 2.6d), making the assump-
tion that objects smaller than 100 pixels represent image noise and anything bigger
represents nuclei. Subsequently, we applied the islet shape as a mask to the image
(shown in Figure 2.6c). However, the resultant image still had overlapping nuclei,
and some artefacts from above and below the 2-dimensional microscopy image plane.
To fix this, we applied an erosion algorithm, using a structuring element of a disk
with radius of 7 pixels (shown in Figure 2.6e). Erosion algorithms work by tracing
around the edge of an object with a structuring element so that overlapping points
are removed. The point of contact between the image and the structuring element is
the centre of the element. In our case, this is the geometric centre of the disk. From
this, the x and y positions of the centres of the remaining areas were stored as the
centres of the nuclei within the islets, and the points around which we dissect the
region into cells. The erosion object was selected in order to provide a balance to
be a big enough shape to disentangle the nuclei, whilst not removing them in their
entirety, obtained through visual inspection and a parameter search.
2.2.4 Identifying the Cell Boundaries
The next step in our analysis was to identify the cell boundaries within the islets.
We did this via an implementation of a Voronoi algorithm, shown in Figure 2.7. We
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had to post process the output from the Voronoi algorithm from the SciPy spatial
library [107]. The reason why it could not be used directly was that it was designed
to be used with the matplotlib library, for graphing, whereas we wished to implement
it with the Scikit Image library, for image processing and therefore we had to modify
the code accordingly.
The Voronoi algorithm represents a decomposition of a metric space (M),
equipped with metric function µ : M ×M → [0,∞) around a finite set of points
(pi ∈M : i ∈ 1...n) [108].
Let x ∈ M be a point in the metric space, then let the bisection between pi
and pj be a subset of points in M denoted by:
Li,j = {x | d(pi, x) = d(pj, x)} (2.8)
This bisection divides the metric space, and denote the subspace containing pi as:
Di,j = {x | d(pi, x) < d(pj, x)} (2.9)
Each Voronoi region V Ri can be considered as an intersection of all the Di,j subspaces










V Ri ∩ V Rj (2.11)
In two dimensional Euclidean space, the most efficient way of computing this
is to find the dual graph of the Delaunay triangulation of a set of point in the plane
(a1...an). A Delaunay triangulation is a way of triangulating a1...an, such that no
point, q ∈ a1...an lies within the circumcircle of any triangle. A circumcircle of a
triangle is the circle defined by the three vertexes of the triangle. The dual graph
upon a graph maps planes to vertexes; mapped vertexes are connected by edges if
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the corresponding faces are adjacent. The vertexes in this dual graph are calculated
to be at the circumcentres of the Delaunay triangles.
(a) Image displaying the cell boundaries, calculated from a Voronoi
algorithm. The nuclei centres, given by the blue spots are based
on Figure 2.6. The white region is identical to the one displayed in
Figure 2.5e
(b) Here the white in Figure 2.7a is overlayed with the hormones from
the original islet image in Figure 2.1.
Figure 2.7: Presented here are firstly the Voronoi split cells, followed by an overlay with
the hormones from the original islet.
2.2.5 Identifying the Type of Cell
In each cell, defined by the Voronoi algorithm, as shown in Figure 2.7a, we needed
to assign it to a type (alpha, beta or delta). This was done by summing the levels of
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each hormone (glucagon, somatostatin and insulin) respectively within each identified
cell (shown in Figure 2.7b) and recording this. The cell type was then determined
from the highest level of hormone within each cell. Due to the effect of the Laplacian
filter on the SST preprocessing, as outlined in Figure 2.3, some of the hormone
staining was removed, so a corrective factor was required. By manually analysing
the ratio of SST mask area to the shape overlayed by the SST hormone mask, in
imageJ, combined with a visual inspection and a small parameter search, this ratio
was calculated to be approximately 1.4. The result is shown in Figure 2.8.
Figure 2.8: Cells were assigned to either alpha, beta or delta, based on their relative
amounts of hormones that they contained. Due to the preprocessing of the SST stains, a
corrective weighting had to be used when assessing these levels.
2.3 Method Validation
We have to test that our results from the image processing matches up to a small,
random selection of cell counts, done by hand, at the UoE Medical School
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2.3.1 Validation of Results
In order to validate the image processing methods, we compared our results with
expert manual analysis of 5 islets from both the T1D and T2D cases and took the
absolute percent difference as the comparison metric. These islets were randomly
selected from both these groups. We then compared our work against results obtained
through the University of Exeter Medical School (UoEMS). Their algorithm was to
firstly record percentage of each islet occupied by the 3 endocrine hormones (SST,
GCG and Insulin). Secondly, they recorded the total cell count. Both these processes
were conducted manually in ImageJ. The results of this algorithm were recorded in
recorded and displayed in the tables below.
After being given the patient identifiers and image numbers, we compiled our
own table from our own results, via our own algorithm. We then compared the two
by calculating the difference in percent composition between their measurements and
ours, and taking the mean. The maximum discrepancy was in the alpha cell counts,
with an absolute percent difference of 12.93%. Given that cell identification within an
islet image is subjective, in general, the fact that our results correspond reasonably
well to those obtained from the UoEMS, provides evidence that the algorithm that
we conducted is accurate.
Presented here are 5 tables. The first is are the cell counts as done by an
expert in UoEMS and the second are the cell counts as done using our algorithm
Figure 2.9. On the second page, these are displayed as percentages of the islet, and
the final table finds the absolute difference in percent composition between the two
Figure 2.10.
2.3.2 Parameter Sensitivity Analysis
Parameter sensitivity analysis is the measure by which the change in parameter in
an algorithm input affects the outputs from the system. In other words it can tell us
how much the uncertainty of the input can affect the reliability of the output.
We have done a parameter sensitivity analysis firstly from the individual sample















T1D nPOD 6038-01PB 1 96 34 57 5
T1D nPOD 6038-01PB 5 39 16 0 15
T1D SC116 7 89 42 0 12
T1D SC116 2 33 17 0 7
T1D nPOD 6086-02PB 9 29 16 0 8
T2D PM138 66 4 2 71 19 38 3
T2D PM138 66 4 3 46 12 27 5
T2D PM184 66 2 10 62 26 29 9
T2D PM192 69 2 42 10 23 6














T1D nPOD 6038-01PB 1 115 32 80 3
T1D nPOD 6038-01PB 5 47 26 3 18
T1D SC116 7 68 51 1 16
T1D SC116 2 28 21 0 7
T1D nPOD 6086-02PB 9 32 23 2 7
T2D PM138 66 4 2 71 22 45 4
T2D PM138 66 4 3 46 13 28 5
T2D PM184 66 2 10 71 17 48 6
T2D PM192 69 2 38 10 19 9
T2D PM192 69 3 121 52 58 11
Figure 2.9: In these two tables, we present the firstly the medical school results followed
by our for analysing the cell counts in a random selection of islets from our sample sets. In
the medical school results, the total cells and the breakdown don’t always add up. This is
due to either the presence of other cell types or uncertainty of cell type.
sensitivity analysis on the population of islet images. We have done analyses to
investigate the stability of the algorithm under perturbations of:
1. The blood Gaussian blur parameter
2. The islet Gaussian blur parameter
3. The local filter window size
4. And finally, the radius of the erosion parameter for the DAPI stains
Subsequently, we plot in Figure 2.11 how varying the parameter changes the cell
count in the individual analysis and the mean number of cells per islet image for the
population analysis.
In Figure 2.11a, we have very little change in cell count with respect to















T1D nPOD 6038-01PB 1 96 35.42% 59.38% 5.21%
T1D nPOD 6038-01PB 5 39 51.61% 0.00% 48.39%
T1D SC116 7 89 77.78% 0.00% 22.22%
T1D SC116 2 33 70.83% 0.00% 29.17%
T1D nPOD 6086-02PB 9 29 66.67% 0.00% 33.33%
T2D PM138 66 4 2 71 31.67% 63.33% 5.00%
T2D PM138 66 4 3 46 27.27% 61.36% 11.36%
T2D PM184 66 2 10 62 40.63% 45.31% 14.06%
T2D PM192 69 2 42 25.64% 58.97% 15.38%














T1D nPOD 6038-01PB 1 115 27.83% 69.57% 2.61%
T1D nPOD 6038-01PB 5 47 55.32% 6.38% 38.30%
T1D SC116 7 68 75.00% 1.47% 23.53%
T1D SC116 2 28 75.00% 0.00% 25.00%
T1D nPOD 6086-02PB 9 32 71.88% 6.25% 21.88%
T2D PM138 66 4 2 71 31.67% 63.33% 5.00%
T2D PM138 66 4 3 46 27.27% 61.36% 11.36%
T2D PM184 66 2 10 71 23.94% 67.61% 8.45%
T2D PM192 69 2 38 26.32% 50.00% 23.68%
T2D PM192 69 3 121 42.98% 47.93% 9.09%













T1D nPOD 6038-01PB 1 19.79% 7.59% 10.19% 2.60%
T1D nPOD 6038-01PB 5 20.51% 3.71% 6.38% 10.09%
T1D SC116 7 23.60% 2.78% 1.47% 1.31%
T1D SC116 2 15.15% 4.17% 0.00% 4.17%
T1D nPOD 6086-02PB 9 10.34% 5.21% 6.25% 11.46%
T2D PM138 66 4 2 0.00% 0.00% 0.00% 0.00%
T2D PM138 66 4 3 0.00% 0.00% 0.00% 0.00%
T2D PM184 66 2 10 14.52% 16.68% 22.29% 5.61%
T2D PM192 69 2 9.52% 0.67% 8.97% 8.30%
T2D PM192 69 3 14.15% 0.95% 10.25% 11.20%
Average 12.76% 4.18% 6.58% 5.47%
Figure 2.10: In these three tables we present firstly the two tables from Figure 2.9 but
as a percent composition of the islets so that they can easily be compared as a percent
difference in table three.
relatively unaffected by this parameter as it primarily affects the designation of cells.
In Figure 2.11b , we vary the pixel edge length of square for the local filter parameter
as outlined in subsection 2.2.3. Between 1 and 13, we see a rapid increase in the
cell count, followed by a plateau and then a slow decline in the mean cell count
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(a) Here, we have on the ‘x’ axis, the Gaussian blur parameter for the SST stained image to remove
the blood. The red dashed line is the default value which is 1. The parameter was tested from 0 to
10 with a stepsize of 0.01.












(b) Here, we have on the ‘x’ axis, the size of the pixel edge length for the square that forms local
filter parameter. The red dashed line is the default value which is 101. This parameter can only be
an odd number. We vary this from 1 to 201 with a step-size of 2.












(c) Here, along the ‘x’ axis, we have the value for the Gauss blur parameter for the overall islets.
The red dashed line is the default parameter which is 10. We vary it from 0 to 20 with a step size
of 0.2.
















(d) Here, the ‘x’ axis is the parameter of the erosion element disk radius. The red dashed line is the
default parameter which has a value of 7, and must be a discrete value. We vary it from 0 to 20
with a step size of 1.
Figure 2.11: Here are the parameter stability analysis for the key parameters for assessing
the number of cells per image. Along the ‘y’ axis, we have the mean cell count per
image. The black solid line represents the mean across all islet images and the dashed line
represents the parameter sensitivity analysis performed on the image in Figure 2.1
within each image. From a parameter sensitivity perspective, our parameter choice
is sensible as there is a low parameter variability in the region of a length of 101
pixels square edge length, which is to say that in the region of 101 pixels the graph
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remains reasonably constant. In Figure 2.11c, we observe a small increase in the
mean number of cells in an image as we vary the Gauss blur parameter for the islet
image. The graph is reasonably constant around our choice of parameter, so this is a
sensible choice from the perspective of sensitivity analysis. Finally, in Figure 2.11d,
we see an initial plateau of values, followed by a moderate decline of cell count with
respect to variation in the parameter of the erosion element. There is a negative
gradient in the graph around our choice of parameter value; however, this is expected,
as when we perform an erosion algorithm on a number of small objects, we would
expect that the larger the erosion element size, the more objects will disappear.
The results from the population average from our parameter search in Fig-
ure 2.11 seem to agree almost exactly with our individual sample analysis. The main
difference is that in the population analysis, the uncertainties are lesser. That is to
say, in all the parameter values in our model, the graphs are approximately locally
constant in the region of our parameter choice lie which is denoted by the dashed
red line in Figure 2.11.
2.4 Statistical Analysis
The primary objective of the statistical analysis is to assess what changes occur
in the islet cellular composition between subject groups and controls as a result
of diabetes. The islets’ cell counts are assumed to depend on 3 significant factors:
the subject group that they come from, variability of cell counts between different
patients within their subject group, along with individual islet variability within each
patient. Subject group refers to whether the patient or islet image belongs to either
the old onset T1D, the young onset T1D, the T2D group or these groups’ respective
controls. Each subject group contains several patients (between 3 and 7, full details
are in Appendix A), and each of these patients have several islet images associated
with them (from 6-12).
Firstly, We need to test the variability of the islet images’ cell counts between
the patients within each subject group to assess whether an islet image has a cell
count dependence on the patient to which it belonged. If this variability is statistically
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significant, then this will need to be accounted for in subsequent tests, by adjusting
the degrees of freedom. By way of example, a patients’ mean beta cell counts within
each islet could be dependent on the type of T1D that they have (recent authors have
suggested that there are several phenotypes of T1D [25]). If this were the case, the
number of independent samples would be the number of T1D patients, as opposed
to the number of T1D islets. Secondly, we then need to test which cell counts are
different between subjects’ islets and their respective controls. Thirdly, we wish to
ascertain the magnitude of the cell changes between the subject islet groups and
their controls. This can be achieved by finding the effect size for these significant
changes.
2.4.1 Testing Islet Variability Between Patients Within Sub-
ject Groups
In order to test the variability of an islet’s cell count between patients, we need to
establish what type of statistical test to use. If the data was normally distributed, this
would be a simple procedure of applying Student’s t-test. However, via application of
the D’Agostino’s K-squared test [109], it was found that the data was not normally
distributed. The D’Agostino K-squared test works by taking the square sum of the
kuritosis and skewness of the data, to calculate a K statistic. If normally distributed,
this K statistic will result in a Chi squared distribution with 2 degrees of freedom. A
Chi squared test then returns a P-value, which can be used to determine if the data
is normally distributed. The mean probability of the groups of data being normally
distributed is 9.27%, so we can reject the hypothesis that the data is normally
distributed at a 95% threshold. We therefore chose to use a non-parametric method
to test islet variability between patients within subject groups.
Given that we wish to test if there is a correlation between islet cell count and
the patient (within subject groups) to whom it belongs, we used a non-parametric
analysis of variance (ANOVA) test, or a Kruskal Wallis (KW) H test. This test works
by ranking the data, taking a square sum penalty for each subjects’ deviation from
the average rank, with a corrective factor for sample size. The mean P value for this
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test was calculated to 0.431% over all the groups, so we reject the null hypothesis that
the cell counts exhibit a dependency on the patient within the subject group. This
suggests that we do not need to correct for clustered data as islets are determined to
have an insignificant association between patients within subject groups. The KW
test is implemented by [110] and the results are recorded in section A.1.
2.4.2 Testing for Cell Type Change Between Subject Groups
Next, we determine whether there is a change in the cell counts between types of
patients and their respective controls. As the data was non-normally distributed, it
was appropriate to use a non-parametric test to compare the samples. The Mann
Whitney U two-tailed test allows for testing if a randomly selected item from one list
would be equal to a randomly selected item from a second list, via ranking the data
and measuring the rank deviation from the mean rank. This was implemented using
a SciPy stats function [111], and the results were recorded in section A.2. Below,
the overall cell counts are shown in Figure 2.12 and cell counts, broken down into
the three endocrine cell types are depicted in Figure 2.13.
The results from the statistical analysis could be summarised as follows:
• In the older onset T1D group, we find significant increase in the delta cell count
between the patients and control, with a decrease in beta cell count. Total cell
count is also decreased between patients and control.
• In the young onset T1D group, we find a significant delta cell count decrease
between the patients and control, with a decrease in beta cell count. Total cell
count is also decreased between patients and control.
• In the T2D we find a significant delta cell count increase between the patients
and control, however total cell count did not show a significant change.
2.4.3 Measuring the Effect Size
We wished to compute the magnitude of change between subjects and their controls.






















Bar chart showing the total number of cells per islet
Figure 2.12: Bar chart illustrating cell count changes between patient type and their
controls.
on the samples. Specifically, the test assesses the probability, Pab of one random





Here, U is the Mann-Whitney U statistic between sample ‘a’ and ‘b’ and na and
nb are the size of the samples of ‘a’ and ‘b’ respectively. This was calculated and
recorded section A.2. If the two groups were identical, we would expect an effect
size of 0.5. We see substantial effect size deviations from this in the beta cell counts
between the young onset and older onset T1D cases, corresponding to autoimmune
mediated destruction of beta cells, as expected. We also see substantial effect sizes
for delta cell counts between the groups, suggesting that there is an increase in delta
cells as a result of diabetes. These effect sizes are illustrated graphically above the
bars in Figure 2.13.
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Bar chart showing the cell count between the 3 cell types
Figure 2.13: Bar chart depicting cell count changes between patients and their respective
controls, split by cell type.
2.5 Summary & Discussion
In summary, we have analysed a set of islet images and compared the different
number of cells between subject and control data; this was done for young onset T1D,
old onset T1D and T2D. Subsequent image processing allows T1D control images to
serve as an input to our model for T1D. Moreover, this additional image processing
allows the T1D subject images to be used for validation of the proposed mechanisms
within the model.
Delta cell type counts appear to have increased as a result of older onset T1D
and T2D, along with the expected reduction in beta cell counts between the two T1D
subject groups and their controls. With respect to the change in the number of delta
cells, we know that there is minimal human post-natal endocrine cell proliferation
[113], so this would imply one of two possibilities: either our previous understanding
of human endocrine cell proliferation is incomplete or we could suggest that the
beta cells might trans-differentiate into other cell types. In fact, the latter has been
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previously suggested by authors such as Weir et al. [114].
In clinical T1D, there is often a delay between diagnosis and need for supple-
mentary insulin injections. This has be referred to in the literature as a ‘honeymoon
phase’ [115]. Cellular trans-differentiation would help to explain this as delta cells
secrete SST, which works to inhibit beta cell function [116]. A loss of beta cells,
reducing insulin secretion capacity, combined with an increase in SST, through an
increase in delta cells could result in a positive feedback loop. This would result in
the sharp decline in glycaemic control, which is frequently observed with T1D onset.
The above results might be useful in providing evidence towards verifying the
trans-differentiation hypothesis; research that has not been previously undertaken
through quantifying and comparing cell numbers within human islets.
2.6 Critical Evaluation
Given that we are working with a small sample size, this could induce relatively high
margins of error. For a given sample probability, p, and a sample size, n, standard






For example, if we have 50 islet samples of a particular subject group and let one
third of the cells be alpha cells. This would yield a margin of error of 6.67%. This
is quite high, and it limits firm conclusions that can be drawn from this work. For
example in Figure 2.13, observationally, it looks as though there are changes in the
alpha cell counts in both the younger and older T1D groups. However, more data
would be required in order to be able to draw a definitive conclusion from this.
There was some subjectivity in which filters were chosen and the parameters
used. For example, when considering the DAPI stain, one could have considered an
ellipse detection algorithm, such as those proposed by Nelson et al. [74]. However,
due to the density of the nuclei and as discussed in the image analysis section, and
that the nuclei overlapped due to the high luminescence of DAPI, this would have
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made machine learning ellipse challenging and time consuming to implement. In
order to account for the high density and overlapping nuclei, we used an erosion
algorithm, and the structuring element was a disc of pixel radius seven as it yielded
results that best accounted for this excess overlap.
There are a variety of algorithms to separate a series of 2D points, corresponding
to centres of nuclei, into cells. This included for example, Sharif et al., who used a
watershed algorithm to segment red blood cells [117]. The review by Irshad et al.
into methods for nuclei detection and cell segmentation provides further reference
into many of these methods [118]. Ultimately, as the images are quadchromatic and
the cells are assumed to be tightly packed, a Voronoi algorithm was used to segment
the cells. Voronoi algorithms have precedence in bio-imaging, for example, Demir et
al. use one for identifying tumours [119].
The constructed false colour maps of the cells (chloropleth) suffered from
random spatially dependent statistical errors. A chloropleth is a map that is shaded
or coloured according to a test statistic and spatial boundaries. In our system, the
test statistic was the level of hormone in a cell and the spatial boundaries were
the cell boundaries as constructed by the Voronoi algorithm. This is clearly an
approximation of the cell boundaries which could cause issues such as cells getting
incorrectly assigned. This kind of statistical error is called the modifiable areal
unit problem (MAUP) [120]. There is no evidence that islet endocrine cells have
predispositions to be particular shapes within the islet, so there is no reason to
believe that any systematic errors have occurred due to MUAP. A worked example
illustrating a MAUP is given below, in Figure B.1.
When compared to the cell count results, obtained by a collaborator in the
UoE Medical School, the maximum discrepancy was in the alpha cell counts, with a
absolute percent difference of 12.93%. As neither cell count necessarily represents the
absolute truth (identifying cells within a human islets is subjective), this is considered
an acceptable error; though our method does eliminate most human biases.
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3. Quantifying the Geometry of
Islets
3.1 Measuring an Islet
In order to make serious progress in understanding any changes as a result of diabetes,
it is important to understand how the overall structure, size and shape of the islet
changes as a result of diabetes. A particular study, by Serion et al., compares the
area of islets before and after diabetes [121], offering contradictory conclusions to
this thesis, in which they say that T1D does not radically change an islets’ geometry:
Only using six T1D islets for comparison, and identifying the islet area by hand as
opposed to an automated algorithm. Despite knowing that the islet secretions are
dependent on the shape and structure of the islet [122], to date, no systematic study
has been performed on islets to assess their structure, either from a qualitative or
quantitative perspective - both in healthy and diabetic patients.
It is therefore important to assess the effect that diabetes has on the shape of
the islets and the effect that shape has on diabetes- to better understand how the
islet secretions change. Furthermore, any future modelling work that would seek to
model proposed spatio temporal mechanisms for diabetes must match the spatial
metric results, outlined in this chapter.
In the previous chapter, we generated binary islet images, B from raw mi-
crograph images (Figure 2.5d). In this chapter we examine the geometry and
macrostructures of islets, using the binary image obtained via the steps taken in
chapter 2. We do not, however, consider the cellular location and decomposition of
islets in this section. This will be further examined in chapter 5.
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For these images, we quantify the islets using the following metrics: area,
perimeter, diameter, pseudo-incircle, pseudo-circumcircle, average radius, isoparamet-
ric radius and perimeter to radius ratio. We formally define these measures below,
and the result are presented in section 3.3.
3.2 Calculating the Different Geometric Metrics
of Islets
From processing the images in the section above, we have a set of two dimensional
images embedded within R2. The following algorithms were written and implemented
in Python3. Where appropriate, morphology definitions follow [123]. We now
introduced some notation which will be useful for formally defining the metrics used
to measure our islets.
Firstly, we recall that the set of binary islet images were defined in the previous
chapter as B, and an individual binary islet image is B. We can index this image
array with p = (p1, p2). We define the coordinate set I as:
I = {1...m} × {1...n}, (3.1)
where m,n is the size of the image in the ‘x’ and ‘y’ direction. In other words B is
the set of pixel points within the image,
B = {Bp}p∈I ∈ B (3.2)
We now define a subset of indexes, IB ⊂ I, which corresponds to the set of indexes
over which the binary image has a value of 1:
IB = {p ∈ I | Bp = 1} ⊂ I. (3.3)
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3.2.1 Filled Image, Erosion and Halo
Given an image B ∈ B we may wish to consider only the ‘external’ boundary of the
shape represented by the filled image. To this end we consider the union S(B) of
connected components of the complement of B that do not intersect the edge of the
image. The filled image is then defined as:
F (B)p =

1 if Bq = 1 or S(B)q = 1
0 otherwise.
(3.4)
for all p ∈ I. An example of F (B) is given by either of the two disconnected
components in binary image Figure 2.5e.
The erosion of B by structuring element k is denoted by εk(B) : B → B. Es-
sentially, the erosion algorithm tracks around the edge of an image with a structuring
element and removes the overlap between structuring element and image. When k is
a disk of radius 1 pixel, we can express the 1-Erosion, ε1 : B → B of B ∈ B as:
ε1(B)p =

1 if Bq = 1 for all q s.t. d(p, q) ≤ 1
0 otherwise.
(3.5)
for all p ∈ I.
The halo is a subset of the filled binary image. It is defined to be the edge
pixels of the filled binary image. This is expressed as H : B → B of the image B ∈ B
to be
H(B) = F (B)− ε(F (B)). (3.6)
An example of a halo is given in pink in Figure 3.4. We define a subset of indexes
IH ⊂ I, which corresponds to the location of the pixels in the halo image which
equal 1.
IH = {p ∈ I | H(B)p = 1} ⊂ I. (3.7)
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3.2.2 Area and Perimeter
A measurement of the area, a : B ∈ B → [0,∞), can be found simply by taking the





There is no such thing as the exact perimeter of a shape in an image. When
calculating from the edge pixels of a shape, one can imagine all of the following as
reasonable interpretations of perimeter distance. Whilst subjective, the approach
Figure 3.1: The above represents the edge of a shape, and three different ways of measuring
the perimeter contribution. On the left, is a simple diagonal line between upper right and
bottom left points on the edge of the image, giving a perimeter contribution of 3
√
17. In
the middle, we use an algorithm whereby we can only travel around the perimeter in the
cardinal directions, giving a perimeter contribution of 13. Finally, on the right, is the
approach that the algorithm that we are using takes in which you can travel around the
perimeter in the cardinal and inter-cardinal directions. this gives a perimeter contribution
of 9 + 2
√
2.
that we took was to use the right hand option within Figure 3.1, as this provided a
balance between following the edge of the image tightly, whilst also being easy to
compute. Once we have a perimeter in pixels lengths, we convert to micrometers-
dividing by the micrograph scaling constant, Sc [124]. We approximate the perimeter,















IH = p1 ∩ p2 ∩ p3 ∩ p4 ∩ p5 (3.10)
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Where p1 ⊂ IH is the set of halo pixels with one cardinally adjacent pixel, as shown
in Figure 3.2a; p2 ⊂ IH is the set of halo pixels with one inter-cardinally adjacent
pixel, as shown in Figure 3.2b; p3 ⊂ IH is the set of halo pixels with two cardinally
adjacent pixels, as shown in Figure 3.2c and Figure 3.2d; p4 ⊂ IH is the set of pixels
with one cardinally adjacent and one inter-cardinally adjacent pixel as shown in
Figure 3.2e and Figure 3.2f. p5 ⊂ IH is the set of pixels with two inter-cardinally
adjacent pixels, as shown in Figure 3.2g and Figure 3.2h.
(a) An example
pixel from the set
p1. p1 is the set of




pixel from the set
p2. p2 is the set





pixel from the set
p3. p3 is the set of
halo pixels with two
cardinally adjacent
pixel.
(d) A second exam-
ple pixel from the
set p3.
(e) An example
pixel from the set






(f) A second exam-
ple pixel from the
set p4
(g) An example
pixel from the set
p5. p5 is the set
of halo pixels with
two inter-cardinally
adjacent pixels
(h) A second exam-
ple pixel from the
set p5
Figure 3.2: Presented here are eight examples of the possible configurations of Perimeter
pixels with surrounding perimeter pixels. To generate all 60 permutations, one simply
rotates the above generator images by {π/4, π/2, 3π/4}
3.2.3 Diameter
Another important measure of shape that we can make is to calculate the diameter
of each islet image, D : B → [0,∞). We define this as the maximal distance between







Where d is the Euclidean distance function. There is however, no algorithm to
automatically do this, but we can construct our own to do this. However, the naive
algorithm would be dependent on the square of the number of pixels in the islet,
for calculating the Euclidean distance between every single pixel in the islet. The
number of pixels in the islet is dependent on the size of the image, so we have a
quartic order of operation, O(m2n2). We observe that an equivalent definition for
the diameter would be the maximal distance between any two points on the halo.
D(B) = D(H(B)), (3.12)
for all B ∈ B. The algorithm for the above would be dependent on the number of
the square of the number pixels in the perimeter - so we have an quadratic order of
operations given by, O(mn). The halo and diameter are shown for our example islet
in Figure 3.3.







(a) Halo of first islet identified in the sam-
ple image from Figure 2.1 with the diameter
overlayed in blue










(b) Halo of second islet identified in the sam-
ple image from Figure 2.1 with the diameter
overlayed in blue
Figure 3.3: Displayed here are the halo of both islets identified in our sample image. From
this, we calculated a diameter, which has been displayed and overlayed in blue.
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3.2.4 Minor and Major Axis
One particularly useful primary measure that can be applied to an image are the







Where i ∈ {0...m} and j ∈ {0...n}. From this, M00 is the area of the islet, and the
centroid, can be given as:
F (B) = 1
M{0,0}
{M{1,0},M{0,1}} (3.14)






(i− F0)o(j − F1)pBi,j (3.15)
The second order moments (M̄{2,0}, M̄{1,1}, M̄{0,2}) gives us the the non-standardized
covariance of the image, the third order moments (M̄{3,0}... etc.) give the coskewness
and the fourth order gives the cokurtosis. An image, much like a probability
distribution, can be fully defined through its moments. The major and minor axis
lengths, ma, mi, respectively are defined to be the major and minor axis lengths of
the elipse with the same second order moments as our images. We can subsequently
approximate a radius, Ra by taking the mean of the major and minor axis length,





3.2.5 Pseudo-Incircle and Pseudo-Circumcircle
The incentre of a shape is the point that is equidistant from each side [125]. It is
well defined for a triangle, regular polygons and some irregular polygons, such as
rhombuses. The shortest line connecting the incentre to each edge is a radius of the
incircle. The incircle is defined as the circle which tangentially touches every side of
52
Figure 3.4: Displayed here are the pseudo-incircles, displayed as yellow circles and the
pseudo-circumcircles, displayed as a cyan circle for the two islets identified within this
image - the islet halo is in pink.
a shape. A property of the incircle is that it is the largest circle that can be fully
encompassed within a triangle or regular polygon.
Similarly, the circumcentre of a shape is a point that is equidistant from each
vertex. The line between the vertex and circumcentre is a radius of the circumcircle.
The circumcentre and incentre are in the same position for a regular polygon. In
addition to being well defined for triangles and regular polygons, the circumcentre
can be well defined for certain irregular shapes, such as an isosceles trapezium. The
circumcircles is defined as the circle which passes every vertex of a shape. A property
of a circumcircle is that it is the smallest circle to fully encompass a shape. A polygon
that possesses both an incircle and circumcircle are bicentric.
Concave polygons can never have well defined circumcircle or incircle. In this
piece of work, we are inducing shapes on digital images, and 2D islet shapes which
happen to have a concave perimeter- due to the folds in the membranes. We define
our pseudo-incircle as the largest disk, centred upon the centroid (F (B)), of B ∈ B,
that can be inscribed in the halo. The radius of this circle is the pseudo-inradius, rin.
Equivalently, rin can be defined as the minimum distance between the centroid and
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the islet halo. Similarly, the pseudo-circumcircle is the smallest circle, centred at the
centroid of the islet, which fully encompasses the islet. The radius of this circle is
the pseudo-circumradius, rout, which could also be defined as the maximum distance
between the centroid and the islet halo.
We can express this by first supposing that c ∈ I and r > 0. We define the
disk of radius r centred at c, C̃(r, c) ∈ B, by:
C̃(r, c)p =

1 if d(p, c) ≤ r
0 otherwise.
(3.17)
and define the circle of radius r and centre c to be
C(r, c) = H(C̃(r, c)). (3.18)
Suppose B ∈ B and c ∈ IB. We define the pseudo-inradius rin of B centred at
F (B) to be
rin(B) = min{r | C(r, F (B))H(B) 6= 0}. (3.19)
Where  is the Hadamard or entry-wise product, and the corresponding
C(rin(B), F (B)) (3.20)
is the pseudo-incircle centred at F (B). Correspondingly, we define the pseudo-
circumradius rout of B centred at F (B) to be:
rout(B) = max{r | C(r, F (B))H(B) 6= 0}. (3.21)
and the corresponding
C(rout(B), F (B)) (3.22)
is the pseudo-circumcircle centred at F (B).
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3.2.6 Dimensionless Measures of Shape
From the basic primary measures above, we can construct a further series of metrics to
analyse the islets. A simple one is the ratio, Qr between the incircle and circumcircle


















Graphical results from the metric calculations are displayed here, as a set of 6
histograms. These graphs have 10 equal bins, so the shape and profile of the data
can be easily compared. The graphs on the left are those of the patients and the
mirroring graph on the right are those of their respective controls. If an islet present
touched the edge of the image, it was discounted as it would be a partial islet image
and therefore give an inaccurate representation of the islet. This left us with 294
islets for comparison, of which 16 belong to the young onset group, 41 belong to
the young onset control group, 89 belong to the T1D group, 47 belong to the T1D
control group, and finally 61 belong to the T2D group and 40 belong to the T2D
control group. These results are analysed in section 3.5
In both Figure 3.5 and Figure 3.6, displaying the histogram of islet areas and
perimeters, respectively, we observe a decrease in the mean of the area in both the
case types of T1D, whilst we don’t see a change in T2D. On the right hand side as a
subject ages.
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Figure 3.5: Presented here are the histograms of the area of the islets, as calculated in
subsection 3.2.2. The horizontal axis represents the area of the islets, given in metres
squared, and the vertical is is the frequency density, normalised so the total area under the
graph is 1.
In Figure 3.7, displaying the histograms of the islet diameter, we see similar
results to Figure 3.5, but the change in shapes look different - we appear to see some
changes in the skewness.
In Figure 3.8, we see a reduction in the mean of the ratio for the pseudo-incircle
and pseudo-circumcircle between the young onset T1D and their respective controls.
We also see this change in the older onset, but there also seems to be a change in
second and third order moment in addition to the mean. We don’t appear to see a
significant change with the T2D and respective controls. We seem to see a reduction
in this ratio with respect to age.
In Figure 3.9 we see a reduction in the mean of the isoparametric radius
between young onset T1D controls and their patients. It’s not clear if this is the case
with the older onset cases or the T2D cases. By comparing the young and old onset
control cases, we can suggest that age seems to lower the mean of the isoparametric
radius
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Figure 3.6: Presented here are the histograms of the perimeter of the islets, as calculated
in subsection 3.2.2. The horizontal axis represents the perimeter of the islets, given in
metres, and the vertical is is the frequency density, normalised so the total area under the
graph is 1.
In Figure 3.10, we see a reduction in mean of the perimeter to radius ration in
the young onset case, but this is not clear in the older onset T1D and T2D cases
and their controls. Age appears to lower the mean of this ratio.
3.4 Summary and Discussion
In this chapter we have used the segmentation of the images in Chapter 2 to quantify
the geometry of islets, and applied it to the samples of human islets that we have
available. This is with a view to apply this to a large number of human islets which
have yet to be imaged at the UoE medical school. Using this data, a full case study
could be made to rigorously analyse how diabetes affects the islets, and also how
ageing affects the islets too - to date, this has not been widely analysed.
Little research has been conducted into the geometry of the islets and how
diabetes affects this. The only studies to date look at the macro-structure of the
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Figure 3.7: Presented here are the histograms of the diagram of the islets, as calculated in
subsection 3.2.3. The horizontal axis represents the diameter of the islets, given in metres,
and the vertical is is the frequency density, normalised so the total area under the graph is
1.
islets have focussed on the area, and stereo-graphically observing how this changes
as one traverses from the head to the tail of the pancreas.
Despite this, there is significant evidence that the geometry affects the func-
tioning of the islets. A greater surface area (represented by perimeter here), provides
greater opportunity for Leucocyte infiltration in the context of the interstital infiltra-
tion theory of diabetes aetiology [126]. A greater volume (represented by area here)
would indicate a greater number of cell and/or more sparse cells [127]. More circular
islets would indicate the cells are close together, and better connected, as opposed
to less circular islets [128].
3.5 Critical Analysis of Results
A change of area within the islet between control and patient groups would indicate
a diabetes associated volume change. A proportional change in area of k between
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Figure 3.8: Presented here are the histograms of the ratio of the radius of the pseudo-incircle
to the pseudo-circumcircle of the diagram of the islets, as calculated in subsection 3.2.5.
The horizontal axis represents the ratio on the islets, given in metres, and the vertical is
the frequency density, normalised so the total area under the graph is 1.
the area of these two groups would suggest an approximate k3/2 change in volume.
The perimeter is also an important measure of an islet to calculate. A change of
perimeter betwixt control and patient groups would indicate that the islets basement
membranes are changing as a consequence of diabetes.
It would be an interesting study to be able to track the individual cells
throughout both the diabetes process and the ageing process. Perhaps, both their
locations an the impact on the islet geometry. However, with current technology,
using ex vivo samples, this would not be possible to directly assess this. That being
said, with future technology, this might become possible.
From our small case study, there appears to be a significant shrinking of the
islets in terms of area, perimeter and diameter as a result of young onset type 1
diabetes. This is expected as beta cells are removed from the system, the cross
sectional area and perimeter would shrink. However, it is not necessarily expected
that the isoparametric ratio, the perimeter to radius ratio and the ratio between the
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T2D_Control, n = 34
Figure 3.9: Presented here are the histograms of the isoparametric radius of the islets as ,
as calculated in subsection 3.2.6. The horizontal axis represents the isoparametic ratio of
the islets, which is unitless, and the vertical is is the frequency density, normalised so the
total area under the graph is 1.
incircle and the circumcircle would shrink. Whilst much more data would be needed
to confirm these results, if it were true, it would imply that the islets become more
folded as a result of diabetes, or that diabetes is causing the islets to fold.
We appear to see similar, if less pronounced results, between older onset T1D
and their respective controls. However, in order to quantify the size of this with
significant degree of meaning, we would like to have an order of magnitude more
data. Such data will likely be available in the next year or so, and will be analysed in
due course. This would indicate either a different mechanism or that the mechanism
for older onset T1D is less potent than the younger onset patients.
However, in type 2 diabetes, there does not appear to be significant changes in
terms of the geometry of the islets in type 2 diabetes apart from the ratio between the
incircle and circumcircle. This could imply something about the islet folds becoming
less pronounced in type 2 diabetes, but more research would need to be conducted
on this.
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T2D_Control, n = 34
Figure 3.10: Presented here are the histograms of the perimeter to radius ratio of the
islets as , as calculated in subsection 3.2.6. The horizontal axis represents the perimeter
to radius ratio of the islets, which is unitless, and the vertical is the frequency density,
normalised so the total area under the graph is 1.
In terms of as the islet ages (Tracking down the control groups from young
onset T1D to older onset T1D and finally T2D) it does not appear that there is a
significant change in the areas, perimeter or diameter, but potentially the three ratio
metrics appears to change, which could tell us about how the islets change shape as
one ages.
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4. Persistent Homology Analysis of
islets
In the previous chapter, we were considering the association between the geometry of
the islets and diabetes and age. In this chapter, we are looking at a more fundamental
classification of an object - its underlying structure, which is independent of the
geometry. For this we will be using a relatively recent branch of mathematics, to
quantify the underlying structure of the islets, called persistent homology.
Persistent homology is the study of the underlying structure of a set of data
and is formally defined in section 4.1. In this body of work, we have generated from
the data given a set of sets of 2D data points, namely the centres of all the nuclei
within the sets of islet images. However, we know that this is a subset of a 3D
data set, namely a 3D islet. If we can gain some insight into what this underlying
structure might look like, we might be able to draw some association between the
islet structures and the impact of both age and diabetes.
Use of topological persistence in biosciences is a relatively new idea. In 2015,
Topaz et al. proposed using barcodes - graphical representations of the homology
- to analyse mathematical models representing biological aggregations such as one
for bird flocks, fish schools and insect swarms [129]. The Vicsek model is a discrete
time, spatially stochastic model which predicts position of a set of particles with
respect to time [130]. Along with a noise term, there is an attraction/repulsion term
to simulate the clustering. By performing persistent homology analysis, it allowed
for the analysis of the connectedness and clustering of biological aggregations, for
example periodicity within murmurings of starlings.
In a similar manner to our work, in 2019 Atienza et al. used a Voronoi
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algorithm, followed by persistent topology analysis to analyse the difference between
cell clustering in the the epithelium of the wings of different stages of development of
Drosophila [131]. This work potentially has applications in wider usage in cell tissue
organisation, as the measurements taken are invariant to noise and scale invariance-
whilst measuring the global properties. Whilst the use of topology in biomedical
sciences is relatively recent, it may have important applications in studying the
underlying properties of tissues, and hence we are investigating it in this chapter.
Within diabetes research Garside et al. have used topological data from retina
scans to investigate and quantify diabetic retinopathy [132]. In this study, they have
created a toolkit for the automatics diagnosis of eye disease based on the topological
changes in a retina scan.
There are two main reasons for using homology with respect to analysing
islet images. Firstly, the number of islets per image (0th Betti number) indicates
the packing density of the islets, and any changes, will give us some idea of how
this might change as a result of diabetes. Secondly, The number of ‘holes’ in each
islet (1st Betti number), could represent either folds in the 3D structure (especially
if close to the edge) or could represent vascularisation. A change would indicate
important changes in vascularisation and folds as a result of diabetes, which would
be functionally significant. This is all the information that we can obtain using
homology on 2D images.
4.1 Definition of Homology
This section largely follows chapter 2 from [133].
Homology is a component of the field of topology. Topology is the study of
structure, two objects are considered topologically equivalent or homeomorphic if
there exists a one to one continuous map between them. Homology is a method
of studying topological equivalence by associating structures, such as simplicial
complexes to Abelian groups.
A simplicial complex is a collection of simplicies. One definition (in the last
paragraph on page 102 of [133]) of a n-simplex, ∆n is a set of n+ 1 points [v0...vn],
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embedded in Rm, such that the points don’t lie in a hyperplane of dimension of less
than n (which requires m > n). Informally, an n-simplex is an ‘n+ 1’ dimensional
generalization of triangle. The ordering of a simplex’s vertices is important and an
‘n-simplex’ denotes an n-simplex with an ordering of its vertices. As a result of an
ordering of of the n-simplex, [v0...vn], we have a natural ordering of the edges [vi, vj ],
with respect to increasing subscript index. [133]. Illustrated below, in Figure 4.1, is




Figure 4.1: Here is an example of the standard n-simplex in Rn+1 for n = 2 - a triangle; we
illustrate the standard 2-simplex [v0, v1, v2] where v0, v1, v2 are the unit vectors as shown
here. This corresponds to the space: ∆n = {(t0, ..., tn) ∈ Rn+1|
∑
i ti = 1, ti ≥ 0, ∀i}, with
the orientation as shown.
The ith face of a n simplex is obtained by removing the ith vertex, denoted by
[v0, ..., v̂i, ..., vn]; the remaining n vertices span an n− 1 simplex. Thus, the vertices
of a face, or of any subsimplex spanned by a subset of the vertices, will always be
ordered according to their order in the larger simplex. The boundary of the n-simplex,
∂∆n, is obtained by taking the union of the faces of the n-simplex, and the open
simplex
◦
∆n is defined to be ∆n − ∂∆n , or the interior of the n-simplex.
A simplicial complex, X ∈ Rn, is a disjoint collection of simplices and can be
defined by the following two properties:
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1. Every face of a simplex of X is in X.
2. The intersection of any two simplices of X is a face of each of them.
Homology associates an Abelian group structure with each simplicial complex
X and each dimension n. Let ∆n(X) be the free Abelian group with basis the
open n-simplices, enα of X. Elements of ∆n are called n-chains, can be written as
a sum ∑α nαenα, where each nα ∈ Z. Alternatively, this n chain could be written
as ∑α nασα, where σα is the map from the various n-simplicies to X. Informally,
this n-chain can be considered as a weighted sum over the simplicial components
of a simplicial complex. The boundary homomorphism can be defined as a map




(−1)iσα[v0, ..., v̂i, ...vn] (4.1)
An example of this operator is illustrated on the first three simplices in Figure 4.2.
As a consequence of Equation (4.1), the composite map of the boundary of the








(−1)i(−1)j−1σ[v0, ..., v̂i, ..., v̂j, ..., vn] (4.2)
which equals zero by arbitrarily relabelling the indexes. A chain complex is the
sequence of homomorphisms of abelian groups between the n-chains of a simplicial
complex:
...→ ∆n+1
δn+1→ ∆n → ...→ ∆1 δ1→ ∆0 δ0→ 0 (4.3)
Equation (4.2) implies that Im δn+1 ⊂ Ker δn. Thence, we define the nth homology
group as the quotient group Hn = Ker δn/Im δn+1. The number of independent
generators for the nth homology group corresponds the nth Betti number. For two
dimensional objects, embedded in R2, this is sufficient to determine the structure of
the object. In the rest of this chapter, an element in a set of independent generators
of the 0th homology group and the 1st homology group are referred to as B0 and B1
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V1V0
+− Boundary of 1 -simplex:
δ1[v0, v1] = [v1]− [v0]
V0 V1
V2
Boundary of 2 -simplex:





Boundary of 3 -simplex:
δ3[v0, v1, v2, v3] =[v1, v2, v3]− [v0, v2, v3]
+ [v0, v1, v3]− [v0, v1, v2]
Figure 4.2: Illustration of the definition of the boundary operator, applied on the first 3
simplices
components respectively.
4.2 Point Clouds and Complexes
We have discussed previously about how we analyse a simplicial complex using
algebra to classify it. We will now discuss how to generate a simplicial complex from
a point cloud - such as we have for the position of the nuclei in the islet images.
These include, but are not limited to, the Rips complex and the Čech complex [134].
These complexes can only be formed on spaces equipped with a metric, as they
require a proximity parameter, denoted with ε. In the Rips complex, the 0-complexes
are generated on the points themselves. The 1-simplexes are generated between
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any 2 points which lie within ε of each other; the 2-complexes and 3-complexes are
generated whenever 3 and 4 points are pairwise within ε of each other respectively.
In the Čech complex k-simplices are constructed where the ε/2 balls around k + 1
simplexes have a non empty intersection. We could use other complexes, such as the
witness complex, for example, but due to its utility and ease of computation, we will
be using the Rips complex. We will now illustrate a Rips complex and a barcode via
an example in Figure 4.3.
The complexes, are largely dependent on the value of ε. Small ε values result
in a cluster of 0-complexes, whilst large ε values result in a monolithic structure.
Both these extremes would tell us nothing about the underlying topological structure
of the image, which leads onto the question: Is there an optimal value for ε, and if
so what is it?
4.3 Persistence and Barcodes
This brings us to persistence. We do not know a priori what the value of epsilon
should be, but as we increase the value of ε, the generated Rips complex grows in size.
That is to say, as ε1 ≤ ε2 ≤ · · · ≤ εM , so we have the following inclusion relationship
for simplicial complexes,
Sε1 ⊆ Sε2 ⊆ · · · ⊆ SεM (4.4)
This sequence is called a filtration. Persistent homology tracks features that persist
along a wide range of values of ε, whilst transient features are considered noise.
Barcodes are a graphical way of displaying the persistent topological features present
throughout a point cloud. In order to do this, we need to track the B0 and B1 com-
ponents, also called the connected components and 1 dimensional holes throughout
the parameter search. This tracking is illustrated in Figure 4.4.
The zeroth Betti number corresponds to the connected components, and the
first Betti number reduces to the number of independent cycles within the network
[135]. Computationally tracking the B0 components is relatively trivial. We can
assign indexes to the nuclei from 0 to the total cell number, which is consistent
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(a) Presented here is an example of a point
cloud of 15 points, pseudo-randomly located
- using a seeded Mersenne twister prime algo-
rithm. From this, we generate a Rips complex
with various distance parameters, ε, to inves-
tigate the underlying structure.
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(b) This is the Rips complex for an epsilon
value of 43 pixels. Note there are now some
linked B0 components. This is the complex
for an epsilon value of 0 pixels
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(c) for certain values of epsilon there is a
B1 component. Illustrated here is the Rips
complex for an epsilon value of 93 pixels
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(d) As epsilon becomes large enough the point
cloud coalesces into one B0 component. This
is the complex for and epsilon value of 181
pixels.
Figure 4.3: Presented here are a series of Rips complex with increasing values of ε We go
from a series of point, which tells us nothing of the underlying structure at one extreme,
to a blob, which similarly tells us nothing of the structure at the other extreme. This leads
to the obvious question of what value should ε be?
across the parameter space. We then take the index with the minimum number
within each B0 component and aggregate it to that indexes bar within the barchart
in Figure 4.5a. We then sort the bars by length order in order to get a sense of
persistence. Presented in Figure 4.5a
For the B1 Barcodes, this is a little more complicated. Each independent ‘hole’
corresponds to an independent cycle. We could, similarly to the B0 components, track
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B0 Rips Coloured. Epsilon isespsilon_93
(a) Here we have an illustration of the
B0 components, for the complex in Fig-
ure 4.3c
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B1 Rips Coloured. Epsilon isespsilon_93
(b) Here we have an illustration of the
B1 components, for the complex in Fig-
ure 4.3c
Figure 4.4: An illustration of how we are tracking the 0th and 1st Betti numbers throughout
the complex.
the vertex with the minimum value, but there could be more than one component
with the same minimum index. Therefore, at each epsilon we value track the
constituent vertexes in each B1 component. If these change, we assign these to a
new B1 component. and record these onto the barchart as in Figure 4.5b.










(a) Here we have the barcode of the B0 components for Figure 4.3. We track the components by the
lowest numbered vertex in the B0 object. As we increase the epsilon values, we notice a decrease in
the number of bars present as we increase the distance parameter. The B0 barcodes are sorted by
length order. The higher up, the less transient the tracked component is.
‘










(b) Here we have the barcode for the B1 complex for Figure 4.3. In this particular example, the
B1 components appear to be relatively transient. We track the the B1 components by the lowest
unique vertex, and if the vertexes change, we label it as a new component
Figure 4.5: These are the B0 and B1 barcodes for the point cloud as presented in Figure 4.3a.
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4.4 Barcode for Sample Islet










Figure 4.6: Here we have the barcode of the B0 components. We track the components
by the lowest numbered vertex in the B0 object. As we increase the epsilon values, we
notice a decrease in the number of bars present as we increase the distance parameter.
The B0 barcodes are sorted by length order. The higher up, the less transient the tracked
component is.
Interpreting barcodes is certainly not an exact science, though, in our case, we
believe that there are two islet components to the islet microscopy slide in Figure 2.1.
However, one could reasonably make an argument that there exist only one islet
sample in this image. Therefore for this particular islet image, a reasonable epsilon
value must be above 85 for this condition to hold. Below, in Figure 4.7, we see the
number of B0 groups, plotted against the epsilon value.
To illustrate this inexactitude within the range of epsilon further, we present
the connected components for a range of 4 epsilon values in Figure 4.8.
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Figure 4.7: Displayed here is the zeroth Betti number, or disjoint components in the islet
image from Figure 2.1 as a function of the distance parameter value. Note the relative
stability between values of 86 and 136. This gives us a good indication of where the true
epsilon parameter should be.
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B0 Rips Coloured. Epsilon isespsilon_63
(a) These are the connected components for
an epsilon value of 63. Here there are many
B0 components - this clearly does not corre-
spond to the sample microscopy image. so
the epsilon value is too low here.
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B0 Rips Coloured. Epsilon isespsilon_86
(b) Here, the epsilon value is 88. Here, the
point-cloud has amalgamated into just 2 dis-
joint components
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B0 Rips Coloured. Epsilon isespsilon_105
(c) Here, the epsilon value is 105. We still
have 2 disjoint components, illustrating the
stability of this region.
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B0 Rips Coloured. Epsilon isespsilon_140
(d) At an epsilon value of 105, the 2 disjoint
components stop being so.
Figure 4.8: Presented here are the connected components, coloured, in order to illustrate
the effects of varying the epsilon parameter value has on the B0 number.
We see on the chart in Figure 4.9 that we have several persistent components,
as well as transient components. To get a better sense of where these lie, we look at
the graph of the count of B1 components against the value of the epsilon parameter,
presented in Figure 4.10.
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Figure 4.9: Here we have the barcode of the B1 components in our sample islet. We track
the components by their vertex identifiers. Going up on the ‘y’ axis, we order barcode
components by length, and along the ‘x’ axis, we have the epsilon value.














Figure 4.10: Here we have a line graph, reducing the barcode to the number of B1
components against the epsilon value
We see clearly in Figure 4.10 that there is a high degree of variability with
respect to the epsilon values on the graph. We will illustrated them for 4 particular
value of epsilon
We see that whilst the number of B0 components remains relatively stable
between 85 and 135, we also see that in this region, from Figure 4.10 that the number
of B1 components does not. In its current form therefore, persistent homology is not
a suitable tool for further understanding the structure and nature of human islets of
Langerhans and more work on it would be required to get additional insight.
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B1 Rips Coloured. Epsilon isespsilon_63
(a) Here, the epsilon value is 66. The B1
components here appear to be somewhat clus-
tered.
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B1 Rips Coloured. Epsilon isespsilon_88
(b) Here with the epsilon value at 88, we see
an increase in the number of B1 components
compared to at 66
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B1 Rips Coloured. Epsilon isespsilon_105
(c) With a epsilon value of 105, we have a
stagnation of the number of B1 components
compared to the epsilon value of 88
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B1 Rips Coloured. Epsilon isespsilon_140
(d) With an epsilon value of 140, there is just
one B1 component present.
Figure 4.11: Graphical illustration of the B1 components for a selection of epsilon compo-
nents. Epsilon values are the same as in Figure 4.8
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5. Quantifying the Islet Cell
Network Structure
In the previous two chapters, we have been investigating the macrostructure of
the islets, and how diabetes changes this. In this chapter, we are investigating the
microstructure changes. We are doing this by inducing a network structure onto the
images, as generated in section 2.2. From here on in, the nuclei centres of cells will be
called nodes, and connections between cells will be called edges. For implementation,
we are using a Python based network library, called NetworkX [136]. By using
an induced network, we hope to test whether there is an association between the
underlying connectedness within the islets and diabetes/age.
5.1 Inducing a Network from Processed Islet Im-
ages
Beginning from the Voronoi tessellation from Figure 2.5e, we take the dual graph
of this. As outlined in, section 2.2 the geometric dual graph gives us the Delaunay
triangulation. The vertices of this triangulation give us a set of nodes, N =
{p1...pn} ∈ R2. The set of lines connecting the Delaunay nodes are called edges are
denoted with ED = {lpi,pj}, where {lpi,pj} is the edge connecting the ith and jth node.
However, this triangulation in a finite, bounded space has two main limitations- that
need to be mitigated to enhance the accuracy.
The first issue is the edges between nodes straying outside the islet domain.
This corresponds to cells being directly connected through the interstitial space,
which would be a modelling error. It was not a satisfactory solution to simply
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remove all the edges that overlapped into the empty space, as it removed edges that
minimally strayed outside, so it did not take into account the concavity of the islet
boundaries. It was neither satisfactory to measure the length of an edge outside the
islet domain, as the folds in 2D are long and snaking, so this retained edges that
should not have been there. A solution was to assess the area enclosed between the
edge and islet. The second issue was particularly long connections at the edge of
the domain as a naive Voronoi tesselation will stretch to infinity. This would result
in cells being modelled as being directly connected over implausibly large distances.
This can be mitigated by defining a new set of edges E ⊆ ED, such that:
lpi,pj ∈ E ⇐⇒ d(pi, pj) ≤ dthresh (5.1)
lpi,pj ∈ E ⇐⇒ Area(B) ≤ Athresh (5.2)





Here, d(, ) is the Euclidean distance function; dthresh and Athresh are constants to be
determined, and B is the binary image of the islet as defined in Chapter 3.
(a) This is the smaller of the two islet com-
ponents within Figure 2.1
(b) This is the larger of the two components
within Figure 2.1
Figure 5.1: Induced network on sample microscopy image as from Figure 2.1. As in
that image, red dots represent α cells, blue dots β cells, and finally green dots are the
δ cells. Red, blue and green lines represent α-α, β-β and δ-δ connections respectively.
The composites magenta, cyan, and yellow lines represent α-β, β-δ and δ-α connections
respectively.
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5.1.1 Discussion on Accuracy and Validity of Network Model
of the Islets
The network is a priori, a mathematical construct, and an abstract representation of
how the cells communicate and interact with each other. We make the assumption
that cells communicate with their immediate neighbours. With gap junctions in
between beta cells, this is definitely a valid assumption. Recent evidence has suggested
that gap junctions might drive cell communications between other islet cell types
[137]. Other types of communication, such as interstitial calcium and cytokines, are
commonly modelled and assumed to follow inverse square law - this would make
modelling via nearest neighbours accurate at a first order approximation [138]. We
are not, however, going to be accurately modelling, for example, the capillary mode
of communication between cells - a different type of model would be needed for
this. Further, our assumption of a maximum distance for communication between
cells was pragmatic, to make sure that cells that are clearly not adjacent are not
connected to each other, but it almost certainly results in some level of inaccuracy.
In previous chapters, we can test the parameters by doing a parameter search and
comparing it to an medical expert’s assessment of where the cells lie. We cannot
do this here, as there is currently no way of telling from the scans by hand exactly
which cells are connected to each other, to independently verify our algorithm.
5.2 Calculating Network Metrics
The motivation behind attempting to capture measurements of the network underpin-
ning islets is to better understand certain aspects of the islets. Examining robustness,
for example, can aid our understanding of autoimmune mediated destruction. The
four metrics that we are proposing capture a wide range of characteristics of the
islets so that we gather insight into how age and diabetes might affect the underlying
structure.
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(a) In this basic example, we have a
mean betweeness centrality of this graph
of 1 and a maximum centrality of 2
(b) In this basic example we have a mean
betweeness centrality of 3/4 and a max-
imum betweeness centrality of 3
Figure 5.2: Both these networks have 4 nodes in 2 different configurations, which both
have different configuration. We can see that in (a) we have 2 nodes that represent the
key centre of the network, whereas in (b) this is 1 node, hence the different betweenness
centrality value.
5.2.1 Betweeness Centrality
Betweenness centrality can be thought of as a measurement of the average ‘importance’
of each node within a network [139]. The betweenness centrality of each node in the







Here, σ(lpi,pj ) represents the number of shortest paths (each edge has a distance one)
between pi and pj and σ(lpi,pj |pk) are the number of shortest paths that pass through
pk. In order to get the mean and maximum betweenness centrality for the network,
we take the mean and maximum values over all nodes. To understand this meaning
further, let us examine two toy examples.
5.2.2 Degree Centrality
The mean degree centrality (md) is a measure of how connected the nodes are [140].
To calculate this, we take the sum of twice the total number of edges in the network,
ne, and divide it by the total number of nodes in the network, np. Max degree
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(a) In this basic example, we have a
mean degree centrality of this graph of
2 and a max degree centrality of 2
(b) In this basic example we have a mean
degree centrality of 3/2 and a max de-
gree centrality of 3
Figure 5.3: Both these networks have 4 nodes in 2 different configurations, which both
have different configuration. We can see that in (a) All nodes are equal and have equal
degree centrality (b) One node has a high degree centrality.






(a) In this basic example, we have a
graph transitivity connectivity of this
graph of 3/5
(b) In this basic example we have a
graph transitivity of 1
Figure 5.4: Both these networks have 4 nodes in 2 different configurations, which both
have different configuration. We can see that in (a) Each node has less edges connecting it
than in (b)
The graph transitivity, also called global clustering Gt is the measure of how
triangulated a network is. Conceptually, this is a measure of a density of a networks
connections [141]. It compares the number of possible triangles present in the network,
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compared to the number of connected triples, or triads. Here, a triad are two edges





(a) In this basic example, we have no
bridges
(b) In this basic example we have 3
bridges
Figure 5.5: Both these networks have 4 nodes in 2 different configurations, which both
have different configuration. We can see that in (a) all nodes are connected to 2 other
nodes whereas in (b) 3 of the nodes have just one nearest neighbor
An edge of a graph is a bridge if and only if its deletion increases the number
of connected components within a graph [142]. In the context of this research, it can
be thought of as a measure of ‘fragility’ of the network.
5.3 Results
We first present the results for the overall networks, followed by the subnetworks of
the beta cell contacts, followed by a brief mention of other potential subnetworks.
Graphical results from the metric calculations are displayed here, as a set of 6
histograms with equal bins, so the shape and profile of the data can be easily
compared. The graphs on the left are those of the patients and the right are those of
their respective controls. n above each of these graphs refers to the number of islets
with non-empty networks for comparison.
There are 294 islet images for comparison, of which 16 belong to the young
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onset group, 41 belong to the young onset control group; 89 belong to the T1D
group, 47 belong to the T1D control group; and finally 61 belong to the T2D group
and 40 belong to the T2D control group. On the horizontal axis is the metric which
is unit-less.
5.3.1 Overall Networks
































































































































Figure 5.6: Presented here are the set of histograms for the number of connected components
per islet. We clearly see an increase in the mean as we travel down the the right hand side
of the histograms, but we don’t necessarily see a change in the shape of the distributions
when we compare diabetes cases to their controls.
In terms of the overall networks, between young onset type 1 and controls,
the mean between centrality (Figure 5.7) does not change but the mean degree
centrality does appear to decrease (Figure 5.8). Whilst the average importance of
each node to keep the graph connected via minimum paths does not change, the
average connectivity of the networks appear to decrease (Figure 5.6). The former
point is supported by the fact that the number of bridges appears not to change
(Figure 5.10). In addition to supporting that the number of minimum paths is
not changing, it would appear that the graph fragility does not change. Somewhat
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Figure 5.7: Presented here are the set of histograms for the mean between centrality metric
for the overall islet networks as calculated in subsection 5.2.1. We appear to see an increase
in skewness with age, and with both types of T1D, but it is unclear if the mean changes.
surprisingly, the global clustering metric does not change under diabetic conditions,
the overall density of the connectivity of the network does not change (Figure 5.9).
Between older onset type 1 cases and controls, we have remarkably similar results to
the younger onset results.
Between type 2 and controls, the mean and max of both the between centrality
and the degree centrality does not appear to change significantly. Neither does the
global clustering metric or the number of bridges. Based on the measures that we
have used, we don’t see significant changes in the underlying networks in type 2
diabetes. Interestingly we also don’t see a change in the number of cells, suggesting
that in T2D, the underlying islet structure is robust.
As someone ages, the number of connected components per islet appears to
increase. In addition, the kurtosis and mean in the mean and max between centrality
distribution appears to increase, whilst the mean and maximum degree centrality
appear to decrease. Suggesting that the importance of each cell to the networks
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Figure 5.8: This is the set of histograms for the mean degree centrality metric for the
overall islet networks. We see the mean appear to decrease as result of age and both forms
of T1D.
appears to increase as one ages, and the number of cells each cell is connected to
decreases. This is consistent with hypotheses about islet cells having very long half
lives, but also not being regenerated in humans.
5.3.2 Beta Cell Subnetworks
In terms of the beta cell networks we see a lot of isolated cells and isolated triples,
hence a number of zeroes and a smaller number of ones recorded in the global
clustering metric histogram (Figure 5.14). These isolated components and somewhat
random nature of the histograms for the T1D cases, is supported by the fact that
many/most beta cells are killed with T1D. Most of the networks left are relatively
isolated. Unless we have orders of magnitude more data, this is all we can conclude
so far about how T1D changes the islets.
Between type 2 and controls, the mean of both the between centrality Fig-
ure 5.12 and the degree centrality (Figure 5.13) does not appear to change significantly.
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Figure 5.9: This is the set of histograms for the global clustering metric for the overall
islet networks. It seems unclear what affect, if at all there is based on age and diabetes.
Neither does the global clustering metric or the number of bridges (Figure 5.15). This
is much the same as the results that we see for the overall network. This thesis would
hypothesise that this is for the same reasons, and overall in T2D, the underlying
beta cell subnetworks are robust.
As someone ages, it appears that the number of connected components per
islet increases (Figure 5.11). In addition, the mean and max of both between and
degree centrality decreases, suggesting that the beta cells become less connected with
each other, in addition to each beta cell in the subnetwork becoming less important.
The global clustering and number of bridges does not appear to change, indicating
that the density and fragility of the beta cell subnetwork does not change.
5.3.3 Other Cell Subnetworks
Here, in Figure 5.16 we can see that for the alpha alpha cell subnetwork, for the data
that we have available, it does not appear that diabetes or ageing significantly impacts
the underlying alpha cell subnetworks. That being said, as beta cells comprise the
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Figure 5.10: This is the set of histograms for the number of bridges metric for the overall
islet networks. Age seems to increase the mean of the number of bridges, as does older
onset T1D. It seems unclear in the other cases if this is the case too.
vast majority of cells in an islet, a significant amount of data is needed to make any
conclusive remarks on this.
5.4 Discussion and Summary
In this chapter, we have created a set of algorithms to induce networks upon islets
from images in chapter 2 and utilised metrics to quantify the resulting networks.
This is with a view to analyse islets and how they are connected, and how this is
associated with diabetes. In addition, network structures capture the underlying
topological features of a structure that the graph approximates [73].
Previously there has been a large body of work, concerning how different
cell types in the islets interact with each other. Beta-beta cells co-operate electro-
physically to simulate islet secretion. Alpha and delta cells are also equipped with
the same types of potassium, sodium and calcium channels as the beta cells, though
the secretion dependencies on these are less clear [143].
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Figure 5.11: Presented here are the set of histograms for the number of connected compo-
nents within the beta cell network per islet. There seems to be a decrease in mean and
skewness in the older onset T1D and T2D cases compared to their controls but an increase
in mean and skewness in the younger onset cases.
Beta beta cell connections have been widely studied and there are many different
types of models to assess and predict their behaviour base on known mechanisms,
such as the calcium model from korošak et al. have created a ‘spin’ model - borrowed
from statistical physics to try to describe this behaviour [144]. Further investigations
have been conducted other islet cell types: Brereton et al. looked into how alpha.,
delta and PP cells might interact with each other via calcium electrochemical channels
[145].
The literature demonstrates that islet cell functionality is linked to the cells
that they are connected to, and whilst there are qualitative descriptions of human
islet architecture such as that by Kim et al. [146], there are no studies which allow
us to assess and quantify these cell connections and how diabetes and age might
affect these. Hence, this chapter has provided a proof of concept toolkit to assess
these connection, which should become more useful as the functionality of the cell
connections becomes clearer.
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Figure 5.12: This is the set of histograms for the mean between centrality metric for the
islet beta cell subnetworks as calculated in subsection 5.2.1. We appear to also see an
increase in skewness with age, and with both types of T1D, but it is unclear if the mean
changes.
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Figure 5.13: This is the set of histograms for the mean degree centrality metric for the islet
beta cell subnetworks. It appears that mean degree centrality decreases in both younger
and older onset T1D diabetes and age.
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Figure 5.14: This is the set of histograms for the frequency density of the global clustering
metric for the islet beta cell subnetworks. It seems unclear as to what is happening within
the global clustering metric due to the number of isolated beta cells as highlighted by the
individual cell present by the spikes on the left hand side of the graph. This leaves very
few results from which to make any inference from.
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Figure 5.15: This is the set of histograms for the frequency density of the number of bridges
metric for the islet beta cell subnetworks. It seems unclear whether there is a change in
the number of bridges here in all cases.

































































































































































Figure 5.16: This is the set of histograms for the frequency density of the mean centrality
metric for the islet alpha cell subnetworks as calculated in subsection 5.2.1.
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6. Discussion and Conclusion
6.1 Results Summary
Here, we briefly highlight some of the main results from chapters 2-5 in Figure 6.1.
We compare these results with the literature, in particular [147] and table 1 from
[148].
6.2 Potential Hypotheses
A summary review table from 2015 with sources of how diabetes changes the cell
counts, vasculature and structure within the islets can be found in table 1 of “New
insights into the architecture of the islet of Langerhans: a focused cross-species
assessment” [148].
6.2.1 Islet Plasticity
In Figure 2.12 we can see that our results seem to suggest that there is a significant
reduction of cell counts as a result of diabetes in both the young onset T1D and
the older onset T1D. However, our results seem to imply that whilst beta cells are
killed some cells seem to become other cell types, called trans-differentiation and
de-differentiation in the literature, as shown in Figure 2.13.
De-differentiation is the idea that a terminally differentiated cell can return
to a more primitive state and trans-differentiation is the idea that a terminally
differentiated cell type can switch lineages [149].
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Islet characteristic Effects of increasing age Effects of young onset
T1D
Effects of older onset
T1D
Effects of T2D
Cell counts (from Fig-
ure 2.12)








α, β, δ cell counts
(from Figure 2.13)




Decrease in β cell
counts, but an in-
crease in α and δ cell
counts
Slight increase in the
number of δ cells
Islet shape (from sec-
tion 3.3)
Islet size does not change - un-
clear whether the islets become more
folded or not (Figure 3.10)
Islets shrink (Fig-




Same as for young
onset but less pro-
nounced
No substantial





The kurtosis and mean of the be-
tween centrality (Figure 5.7) mea-
sures appears to increase whilst the
degree centrality (Figure 5.8) ap-
pears to decrease whilst connected




Same as for the
younger onset cases
No significant changes
to the network struc-
ture in T2D
β cell network con-
nectivity (from sub-
section 5.3.2)
Between and degree centrality (Fig-
ure 5.12 and Figure 5.13) both de-
crease and connected components




Same as for younger
onset cases
No significant changes
to the β cell network
structure in T2D
Figure 6.1: Table highlighting the key results from the thesis
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For T1D, in Figure 2.13, our results may even suggest that for younger onset
type 1 cases, there is little trans-differentiation happening and the insulitis is killing
all cell types. This is supported in the literature as it has been widely reported that
younger onset T1D tends to be more aggressive [150, 151, 152]. Therefore, it would
be interesting to further investigate whether both alpha and delta cells are killed in
addition to beta cells in younger onset T1D cases.
In older onset T1D, our results would seem to imply that less overall cells are
killed than the younger onset, though potentially more beta cells are killed. The
reason for this difference is appears to be that there are more alpha and delta cells.
We hypothesise that this is due to cellular trans-differentiation, which is further
supported in the literature [153, 154, 155].
In cases of T2D, we don’t see a significant change in the total cell count, alpha
cells and beta cells, though we see an increase in delta cells. It has been hypothesised
by for example Wang et al. and Jain et al. that changes in beta cell numbers can
vary highly between islets - location within the pancreas appears to be a factor [5], as
does age of onset [156]. However the literature suggests that cellular dedifferentiation
does occur in T2D. Once we have spatially and age aggregated image data, we could
use this toolkit to test these hypotheses.
6.2.2 Islet Shape Changes
Within the literature, it appears that two major factors that influence the shape of
islets is age and diabetes, though it appears that most research to date make weak
implications with regards to shape change and islets. For older people their islets
are less dense and have less beta cell mass [157]. One would therefore expect as a
non-rigid body that the islets would become smaller as a result. To quote Matsuda,
“Age related pathological changes in the pancreas have been unclear because they
are often minor and non-specific. However, recent studies have shown that they
are closely related to various pathological conditions such as pancreatic cancer and
diabetes mellitus.” [158]
From our results, as one ages, it does not necessarily appear that there is a
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change in mean in the diameter or cross sectional areas of the islets (Figure 3.5)
- though there could be some changes within the moments of the data which be
interesting to analyse with more islet samples. However, we do see a reduction
in the mean of the isoparametric ratio (Figure 3.9), the perimeter to radius ratio
(Figure 3.10) and the incircle to circumcircle ratio (Figure 3.8), which means that
we hypothesise as one ages, the islets are becoming more folded.
With regards to diabetes related shape changes, the literature regarding shape
changes is similarly sparse - especially for T1D, but has also been implied as being
important with regards to islet function . Within type 1 diabetes, among caprine
models for example, Hani et al. suggest that type 1 diabetes can cause changes to
the surrounding islet membrane, triggering islet deformities and affecting function
[159]. Due to a reduction in beta cell mass, one would naturally expect a reduction
in islet size but to date no quantitative study has been done on this.
As a result of T1D, we hypothesise that we see a significant reduction in the
mean islet cross sectional areas (Figure 3.5), diameter (Figure 3.7) along with the
isoparametric ratio (Figure 3.9), the ratio between the incircle and circumcircle
(Figure 3.8) and the perimeter to radius ratio (Figure 3.10). In other words, we
hypothesize that not only do the islets shrink as a result of T1D, but the islets also
become more folded. We also hypothesise that the results are more pronounced and
extreme in the younger onset patients than the older onset cases
With type 2 diabetes, it would appear that there is an increase in starfish
shaped islets in rodent models [160]. There is mixed evidence of islet hypertrophying
and atrophying in different circumstances, potentially dependent on the region in
the pancreas. However this induced size difference likely has an affect on insulin
secretion, so quantifying this is important to understand this better.
As a result of T2D, we don’t see significant changes in between diabetic and
their controls in terms of the geometry, however more data is required, especially at
the extremes to assess the impact of atrophying and hypertrophying islets.
93
6.2.3 Vasculature and Islet Destruction
The literature is quite clear that vessel density is increased in diabetic patients as
opposed to non-diabetic patients, though the vessels themselves are smaller in T1D
cases [161, 162, 11, 163]
From our methodology, if it were to be made more robust, we would speculate
that we would see an increase in the Betti numbers from the images as we moved
from healthy patients to diabetic patients.
6.2.4 Islet Connectivity Changes
The cells within a pancreas interact with each other, electrochemically - a review
by Koh et al. provides a succinct overview of what is known about the interaction
between cell types in the pancreas [164].
Just as cells interact with each other ionically, it has become vogue in recent
years to model cell clusters within islets as networks. For example, Johnston et al.
considers beta cell hubs, which act as ‘pacemakers’ within beta cell networks [165].
Further there have been many ODE system models which describe the interaction
between paracrine cell types. Among the most comprehensive to date is one that
models the interactions of alpha, beta delta cells [166].
As a result of T1D, our results suggest the islets become less connected,
with many cells being killed. With T2D, we don’t find any significant changes to
the underlying network for diabetes. On the other hand, as one ages, whilst we
don’t see high levels of cell loss, we do see the islets become less well connected -
reflected especially in the increasing number of connected Figure 5.6 and Figure 5.11
components per islet.
6.3 Result and Impact Discussion and Summary
Chapter 1, is a literature review: Firstly, we outline a definition of diabetes, followed
by an outline of the strucuture of the pancreas, the islets and cells contained within.
Secondly, it contains a review of the current knowledge of the epidemiology and
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aetiology of diabetes, both type 1 and type 2. Finally, there is a brief review of
current literature of morphometry and the study of image analysis with application
to biosciences.
In chapter 2, we firstly describe the data that we receive from the medical
school, followed by a description of how the data was processed and analysed into
spatial data. The algorithm developed to analyse the islets is a novel contribution to
the field. Building upon this, we analysed the output of the algorithm to assess the
effect of diabetes upon the number of insulin producing beta cells, along with the
alpha and delta cells. This original analysis has yielded some interesting results -
beta cell numbers are reduced in both classes of T1D, but stay the same in T2D,
as has been previously proposed. Interestingly, it appears that the number of delta
cells present increases in T2D and the older onset T1D, where as there is a decrease
in T2D. Ghrelin producing delta cells regulate appetite as well as insulin release, so
whilst we are not sure of the mechanism, this could have a significant impact on
treatments.
In chapter 3, the spatial data generated as a result of chapter 2 to analyse
how diabetes changes the shape of the islets. The form of an islets is functionally
relevant, for example, folds in islets. By systematically analysing these features,
we have assessed how the shape of the islets change associated with diabetes. our
preliminary results would seem to indicate the islets shrink as a result of type 1
diabetes, especially the younger onset patients. This is corroborated in the literature
and is called pancreatic atrophy [167, 168, 169]. On the other hand, in type 2
diabetes, we do not see similar results with regards to how the shape changes as a
result of diabetes. This does not correspond to the literature - though the literature
does focus on rat models [170, 171]. However, this could as a result of aging as
opposed to the type 2 diabetes. We seem to see a growth in islets between the young
onset type 1 controls to the older onset type 1 controls, followed by a shrinking of
the islets to type 2 controls, with an increase in the variance throughout. This has
not been previously studied in detail before, and whilst we would need more data to
verify this, might provide some interesting insight into islet behaviour as a healthy
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person ages.
In chapter 4 we build upon the use of the spatial data to analyse how the
structure of the islets are affected by diabetes. However these structural results did
not appear to be stable over a range of parameters in 2D. Analysing structure is
an exciting new idea, which might be more viable in the 3D structure that islets
actually inhabit.
In chapter 5 we firstly induced networks on islet images - processed in chapter 2.
We then utilise several metrics from the NetworkX package to analyse these graphs
with and have generated a toolkit to analyse the cell networks in islets, both as a
totality and as a function of the different cell types. In general as one ages, our results
would suggest that the networks become more disjointed, and whilst type 1 diabetes
causes there to be less connections overall, type 2 does not. This is consistent with
the literature, suggesting that cells are killed in type 1 diabetes, but there is a lack
of evidence for this being the case in type 2 diabetes
A serious limitation of the work is that the data we are using in both the image
analysis and model is a 2D projection of 3D data. Three dimensional data would
allow additional degrees of freedom. Since we do not have access to 3D human islet
images, this is beyond the scope of our investigations. When and if we are able to
do this, 3D islet images could be used in an extension to this work.
6.4 Future Plans
6.4.1 Network Dynamic Model for Islet Secretion
By arbitrarily labelling the nodes representing cell centres within the islet, it would
be possible to create a Markov chain islet secretion simulation model. The major
diagonal values in the Markov chain would be the self-simulation which would
allow us to understand spatial temporal behaviour, both under healthy and diabetic
conditions. The stochastic matrix would be sparsely populated, allowing for easy
identification of the egienvalues/vectors, so one could analyse the periodicity for
short, medium and long term cycles as has been first identified and mathematically
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analysed by Bertram and Sherman in 2000 [14].
Markov chain systems have been used in biosciences, specifically in neuro-
sciences so model things such as ion-channel release modelling [172]. By taking the
limit of time period between state changes in a Markov chain down to zero, we can
create an ODE system, constrained to the region of the islet network connections.
Describing the secretion state of the cells within the islet as a function of time.
These models would only include direct cell-cell contacts. We know that there
are other modes of intracellular communication within the islets, such as via the
vasculature [173]. We are, however, interested in how base behaviour of islets changes
as a result of diabetes, but also how islets change as one ages - something that has
not been widely researched in humans. Such models would be an interesting place
to start.
6.4.2 Cellular Automata Model for Insulitis
We could construct a cellular automata to simulate the autoimmune destruction
of beta as present within T1D and hypothesised to be present in T2D. There are
several advantages and disadvantages to various model types - the feasibility and a
basic outline for this potential project are given in Appendix C.
6.4.3 3D Islets
One of the biggest weaknesses of this research is that we do not look investigate 3
dimensional islets. Real 3D data at the resolution explored in this thesis does not
exist for islets for humans. Whilst 3D scans have been taken of animal islets [174]
it has been previously established that animal islets just are not similar enough to
human islets to extrapolate results from them. If and when 3D human islet scans
become available in significant enough quantities, they should be analysed in a similar
fashion to what we have done here. As 3D islets would potentially have a lot more
geometric and topological complexity than 2D islets, we would expect to be able to
capture much more subtle aspects of the vasculature within the islets.
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6.4.4 Constrained Voronoi
In our analysis, we have used a Voronoi algorithm in R2 and masked it using the cell
outline. Research has been done by [175] in which more general Voronoi algorithms
are developed and applied on restricted domains. In such cases a partition is found
that considers only paths within the restricted domain. This would be difficult to
implement, but directly applicable to our problem, and increase the accuracy of the
cell designation and hence the overall results.
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A. Results Tables
A.1 Intra Patient Type Table
Kruskal-Wallis Pt Sample
Dataset P-Value Count Size
Old onset #alpha cells per islet 2.05× 10−2 6 57
Old control #alpha cells per islet 1.12× 10−3 7 72
Old onset #beta cells per islet 2.87× 10−3 6 57
Old control #beta cells per islet 1.11× 10−23 7 72
Old onset #delta cells per islet 4.50× 10−1 6 57
Old control #delta cells per islet 1.40× 10−17 7 72
Young onset #alpha cells per islet 7.10× 10−5 5 11
Young control #alpha cells per islet 6.61× 10−3 4 32
Young onset #beta cells per islet 1.11× 10−4 5 11
Young control #beta cells per islet 1.44× 10−3 4 32
Young onset #delta cells per islet 3.27× 10−3 5 11
Young control #delta cells per islet 1.66× 10−1 4 32
T2D #alpha cells per islet 5.44× 10−1 5 50
T2D control #alpha cells per islet 5.48× 10−1 3 28
T2D #beta cells per islet 1.01× 10−2 5 50
T2D control #beta cells per islet 5.21× 10−3 3 28
T2D #delta cells per islet 5.27× 10−1 5 50
T2D control #delta cells per islet 7.64× 10−6 3 28
Presented here is a table comparing patients within each subject group, using the
Kruskal Wallis H test. We use this to assess as to whether we need to correct for a

























































































































































































































































































































































































































































































Presented here is a table comparing between patients groups and their respective
control groups, using the Mann Whitney U test. We use this to assess if there has
been a significant change in various cell counts and their respective controls.
100
B. Modifiable Unit Areal Problem
(MUAP)
The modifiable unit areal problem is a problem involving the introduction of bias
relating to spatial statistics in image analysis. As a spatial problem, it is perhaps
best explained pictorially in Figure B.1 and is largely self explanatory on viewing
the image. The most recognisable application in popular culture is ‘gerrymandering’.
Common in first past the post electoral type systems, gerrymandering is the practice
of establishing district boundaries in order to gain more representation than support
would typically allow. A typical example of this is in the US in which a candidate
may lose the ‘popular’ vote but still win an election.
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40 % red hormone
60 % green hormone
0 1 2 3 4
X Pixel Count
Division 1
2 red, 3 green



















0 red, 5 green
0 1 2 3 4
X Pixel Count
Division 3
3 red, 2 green
Figure B.1: An image plot demonstrating the modifiable areal unit problem. In the top
left, we see an ‘image’ with 50 pixels. 20 are red hormone, whilst 30 are green hormone.
From that, if we were to divide this in 5 cells, we would expect there to be 2 red cells and
3 green cells when assigning based on the hormone presence within the cell. In the top
right, we see 2 red cells and 3 green cells, as expected. In the bottom left, the cell
division yields no red cells and 5 green cells. However, in the bottom right there are 3
red cells and 2 green cells.
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C. Cellular Potts Model for
Insulitis
C.1 Converting to Image Data for Modelling
In order to make the islet images images suitable as an input for the computational
model of beta cell destruction, it was necessary to reduce the resolution. This is in
order to run simulations of the model in a reasonable amount of time for a large
number of samples, especially during the development phase. Initially, the centroid
of all the cells was rescaled from 1296 by 966 to 100 by 100 pixels. Subsequently,
every islet pixel in the rescaled image was assigned to its nearest relevant centroid.
The resulting image is shown in Figure C.1. For example, blue pixels looked for
the nearest SST cell centre, via looping through all the centres and calculating the
Euclidian distances. After assigning each islet pixel to a cell, each cell was recorded
with its type and all its pixels as 1 dimension index array and saved to a .txt file;
the 1 dimension index was recorded as row major index which is to say:
Index(i, j) = i+ j × imax, (C.1)
where i and j are index positions; imax is the horizontal pixel size of the image.
C.2 Types of Cellular Automata Models
Our goal is to identify and test various mechanisms for beta cell destruction in
the pancreas. Using the image processing techniques outlined above in section 2.2,
we can obtain data regarding cell positioning within the islets for both the age
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Pixelated cells. Alpha cells are red. Beta cells are blue.
Delta cells are green. Islet is: 5 and patient is: T2D c ntr l PM 202 75 17.7.2017
Figure C.1: Image of example islet with resolution reduced to 100 by 100 pixels.
matched controls and T1D subjects. From a modelling perspective, this is assumed
to be before (control data) and after T1D (subject data), respectively. Using
spatio-temporal models, as outlined in the thesis aims, will help us understand the
underlying immune mediated T1D mechanisms better. This cannot be done via more
conventional methods, such as dissections or animal models, due to the location and
enzymatic nature of the pancreas, as discussed in the introduction.
According to a recent review by Osborne et al. [176] there are 5 major ways
in which the motility, genesis and apoptosis of cells within tissues are currently
computationally modelled. Two similar models in modern cell research are the
Voronoi tessellation model and the vertex model. In a Voronoi tessellation model,
the cells are assumed to be polygons, and a set of points corresponding to a bijective
map with a unique point inside each cell. The positions of these points, also known
as seeds, vary as a function of time with according to Newtonian mechanics [177].
A Voronoi tessellation is constructed about these points in order to represent cells.
Cells are similarly assumed to be polygons in the vertex model. However, it is
the vertices of cells that change position with respect to time, with each vertex
representing a common point between 3 or more cells [178]. However, both of these
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models assume a dense cell tissue structure, which is not representative of human
islets within the pancreas. A further model type that we considered as a framework
for solving our research questions is of a cellular automata type. This is an on-lattice
model, which means that space and time are discretised [179]. In this model, each
cell is represented by a pixel and these evolve with respect to time, explained further
in Figure C.2. This model type was used by Ozturk et al. to construct a model
for T1D insulitis in mouse islets [180]. However, given that we wish to investigate
how geometry affects beta cell destruction, one uniform pixel per cell would not be
sufficiently representative of the morphology of the cells and islets.
Figure C.2: An illustration of how cells would look in a cellular automaton model. Each
cell (closed square) is anchored to a lattice site (black dot). A valid move on a time update
can either be to stay put, or move to an adjacent lattice site, if that site is not already
occupied by an existing cell.
Another modelling framework, the overlapping spheres model has been used by
Wedgwood et. al [181] to develop a spatio-temporal model for insulitis. Overlapping
spheres models are circular (in 2D) and interact with each other when the centres of
the cell are within a certain range; this can be thought of as the cell radii. In the
Wedgwood model, the white blood cells were assumed to be attracted to the beta
cells, within the islets, via a freely diffusing chemokine gradient. This was modelled
using a reaction-diffusion equation. Solving this equation analytically relied on the
assumption that the islets were circular. From the data above, however, it is clear
that the islets are not circular. In our model, we aim to use a realistic islet geometry
that would require solving the reaction-diffusion equation numerically.
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C.3 Cellular Potts Model
The framework that we would like to use to build our model is a cellular Potts
framework. A cellular Potts model (CPM) is an on-lattice model where all cells
consist of a number of pixels [182], illustrated in Figure C.3. Allowing multiple pixels
per cell within a CPM, as opposed to cellular automaton models with a single pixel
per cell, allows for more realistic cell and tissue geometry to be realised, which is a
clear advantage.
Figure C.3: An illustration of how cells (illustrated by the closed shapes) are modelled in a
CPM. A cell is a set of connected lattice points. How they move on each time update, and
what connected means in this context is outlined below.
A CPM works as follows: firstly, each cell has a set of valid moves that it can
take which are calculated and recorded. A valid move (Figure C.4) for a cell is to
extend into adjacent empty pixels, or contract, such that the cell is not split into
two.
Secondly, a move from this set is chosen randomly. Thirdly, a Hamiltonian of the
current lattice and the lattice after the proposed move is computed. A Hamiltonian
in this context refers to the energy present due to the lattice configuration [?]. In
2D, this can be decomposed into three components:
H = Harea +Hadhesion +Hchemical (C.2)
This overall Hamilton can be split into the Hamiltonian due to the area (Harea), a
Hamiltonian due to a cell-cell contact (Hadhesion), and finally a Hamiltonian due to
the presence of chemokines (Hchemical). The Hamiltonian contribution due to area
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(a) Presented here is a 4 pixel,
‘L’ shaped cell, adjacent to an-
other cell (comprising of 3 pix-
els).
(b) Illustration of the Neu-
mann neighbourhood move
set upon Figure C.4a
(c) Illustration of the Moore
neighbourhood move set upon
Figure C.4a
Figure C.4: An example of different sets of moves that a cell can make, depending on how a
neighbourhood is defined. In green are cell expansion moves and in red are cell contraction
moves. A cell cannot expand into another cell and whilst contracting, it cannot split to
make two cells. In a CPM, the pixels constituting each cell must be either 4-connected
(Neumann neighbourhood), which means that each pixel in a cell must have an adjacent
cell pixel in one of the 4 cardinal directions, as illustrated in Figure C.4b. In the Moore
neighbourhood, the 8 adjacent pixels in cardinal and inter-cardinal directions are said to
be 8-connected, illustrated in Figure C.4c.




λA (A (σ, τ)− Atarget (σ, τ))2 +
∀ cells∑
σ
λP (P (σ, τ)− Ptarget (σ, τ))2 ,
(C.3)
where, σ denotes an individual cell, and τ is a type of cell. A (σ, τ) and P (σ, τ) are
the cells current area and perimeter, respectively, and Atarget (σ, τ) and Ptarget (σ, τ)
are the cells target area and perimeter. λA and λP are area and perimeter elasticity
constants, respectively. The area Hamiltonian is the square sum penalty for the devi-
ation from each cells target area and perimeter. The adhesion contact Hamiltonian




Jτ(σ)τ ′(σ′) (1− δ (σ(i, j), σ′(i′, j′))) , (C.4)
where, as before σ denotes an individual cell, and τ is a type of cell. i, j denote
cellular lattice positions around the edge of a cell; Chen et al. [183] suggest using
a depth of 4 pixels from the edge of a cell. The Kronecker delta, δ(σ, σ′) ensures
that only surface sites between different cells are considered. Jτ,τ ′ is the binding
energy per unit perimeter. This binding energy constant can be positive or negative,
depending on the type of cell-cell interactions. The chemical potential Hamiltonian
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where, C(σ) is the chemotactic gradient summed over the lattice positions of each cell.
µ(τ) is the chemotactic attraction constant over different cell types. The chemotactic
gradient can be modelled via a reaction diffusion equation, which can be implemented
discretely upon the lattice. The chemical potential Hamiltonian sums over the cell
lattice positions and takes the product of the chemical potential at that position and
the attraction constant of the cell. Finally, the energy difference, ∇H is calculated
between the cells both before and after a proposed move is taken. If the proposed
move has a negative energy change or exothermic change associated with it, then it
is accepted unconditionally. If the proposed move has a positive energy change, then
it is endothermic and is accepted with a probability of exp(−∇H/T ), where T is
the ‘temperature’ of the system; a number which when zero will allow a cell to only
move in exothermic steps, but when infinite will allow the cell to move randomly,
and not be bound by energy considerations.
The model will include beta cells which produce a chemotactic gradient that
will recruit white blood cells to destroy the beta cells. This gradient will be based
upon research by Christen et al. [184], and chemokines will be assumed to diffuse
freely. There will be inert non-beta cells, representing the other cell types present
in the pancreas. The location of the islet cells will be obtained from the processed
microscopy images. There will be two types of white blood cells, CD20+ B cells and
CD8+ T cells. The CD20+ and CD8+ will cooperate when close enough to activate
the CD8+ T cells to secrete a β cell killing cytokine. This will be implemented by
applying work by authors such as Scianna et al. [185] regarding implementation of
cell motility in CPM.
We plan to build on this model further by introducing a basement membrane.
This is a protein encapsulation of an islet, and has been implicated by various authors
such as Kragl et al. [186] and Otokoski et al. [187] in protecting the islets from
leukocyte infiltration (as discussed in the introduction). We would also like to add
in CD48+ macrophages. Maree et al. have constructed a temporal model for this
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specific infiltration [67], which we will use to inform modelling these leukocytes.
We are implementing this model in an library called CHASTE (standing for
Cancer, Heart And Soft Tissue Environment; see [188]). Developed by programmers,
mathematicians and biologists at Oxford university, this library, written in C++, is
used in biomedical research to allow simulations of tissue behaviour in silico.
The first step to construct this model is to input realistic islets. For this, we
plan to insert alpha, beta and delta cells into the model for the start of the simulation,
the positions of which we obtained from the post processed images, as outlined in
section C.1.
Figure C.5: Visual output from CHASTE, demonstrating the cells inserted in the model,
processed from Figure 2.1 .
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D. List of Abbreviations
The following table describes the significance of various abbreviations and acronyms
used throughout the thesis. The page on which each one is defined or first used is
also given.
Abbreviation Meaning Page
B Processed, binary image of an islet 23
B The set of processed, binary images of the islets 23
GCG Glucagon 3
SST Somatostatin 3
T1D Type 1 Diabetes 6
T2D Type 2 Diabetes 6
UoEMS University of Exeter Medical School 17
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